<html class="gs_el_sm gs_pfcs"><head><title>‪Robert F Storey‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=-plVGtcAAAAJ&amp;hl=en"><meta name="description" content="‪University of Sheffield‬ - ‪‪Cited by 77,400‬‬ - ‪Cardiology‬ - ‪atherothrombosis‬"><meta property="og:description" content="‪University of Sheffield‬ - ‪‪Cited by 77,400‬‬ - ‪Cardiology‬ - ‪atherothrombosis‬"><meta property="og:title" content="Robert F Storey"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=-plVGtcAAAAJ&amp;citpid=1"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"BARSYbXmEPKTy9YP0q2C4Ac"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=-plVGtcAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYVNVhN63u0PoNsT1fYL49DGbMK7HWSwX"><input type="hidden" name="user" value="-plVGtcAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">77400</td><td class="gsc_rsb_std">48291</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">91</td><td class="gsc_rsb_std">74</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">264</td><td class="gsc_rsb_std">234</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:518px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:472px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">10000</div><div class="gsc_g_xtl" style="top:73px;">5000</div><div class="gsc_g_xtl" style="top:113px;">2500</div><div class="gsc_g_xtl" style="top:33px;">7500</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:154px;height:6px;z-index:14"><span class="gsc_g_al">430</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:147px;height:13px;z-index:13"><span class="gsc_g_al">860</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:135px;height:25px;z-index:12"><span class="gsc_g_al">1612</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:122px;height:38px;z-index:11"><span class="gsc_g_al">2420</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:94px;height:66px;z-index:10"><span class="gsc_g_al">4177</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:82px;height:78px;z-index:9"><span class="gsc_g_al">4932</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:68px;height:92px;z-index:8"><span class="gsc_g_al">5764</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:55px;height:105px;z-index:7"><span class="gsc_g_al">6605</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:39px;height:121px;z-index:6"><span class="gsc_g_al">7623</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:41px;height:119px;z-index:5"><span class="gsc_g_al">7440</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:28px;height:132px;z-index:4"><span class="gsc_g_al">8252</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:33px;height:127px;z-index:3"><span class="gsc_g_al">7940</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:13px;height:147px;z-index:2"><span class="gsc_g_al">9202</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:40px;height:120px;z-index:1"><span class="gsc_g_al">7553</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=-plVGtcAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3d-plVGtcAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>68 articles</span></div><div class="gsc_rsb_m_na"><div>18 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:21%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:109px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:68pt;height:80pt;}}</style><img alt="Robert F Storey" sizes="print 68px,109px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=-plVGtcAAAAJ&amp;citpid=1" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=-plVGtcAAAAJ&amp;citpid=1 109w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=-plVGtcAAAAJ&amp;citpid=1 219w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Robert F Storey</div><div class="gsc_prf_il"><a href="/citations?view_op=view_org&amp;hl=en&amp;org=9829198446306616343" class="gsc_prf_ila">University of Sheffield</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at sheffield.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:cardiology" class="gsc_prf_inta gs_ibl">Cardiology</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:atherothrombosis" class="gsc_prf_inta gs_ibl">atherothrombosis</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYVNVhN63u0PoNsT1fYL49DGbMK7HWSwX"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=-plVGtcAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Third universal definition of myocardial infarction</a><div class="gs_gray">ESC Committee for Practice Guidelines (CPG), ...</div><div class="gs_gray">Journal of the American College of Cardiology 60 (16), 1581-1598<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3841597114172584481,8096220421405192992,14629061266043301663,18077100438852477144,11812269843241089052,6186120825998865048,17983662617269369105" class="gsc_a_ac gs_ibl">15810</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="-plVGtcAAAAJ:u5HHmVD_uO8C">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with acute coronary syndromes</a><div class="gs_gray">L Wallentin, RC Becker, A Budaj, CP Cannon, H Emanuelsson, C Held, ...</div><div class="gs_gray">New England Journal of Medicine 361 (11), 1045-1057<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2464584237372164671" class="gsc_a_ac gs_ibl">7066</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European&nbsp;…</a><div class="gs_gray">Ž Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">European heart journal 32 (14), 1769-1818<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9206894728315982494,16109818192750629412,11911107929288944208,5630608142339921461" class="gsc_a_ac gs_ibl">6460</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="-plVGtcAAAAJ:9yKSN-GCB0IC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation</a><div class="gs_gray">M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...</div><div class="gs_gray">Kardiologia Polska (Polish Heart Journal) 73 (12), 1207-1294<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17992990069601380174,11269061242453501270,16368896017931933495,4330301785314607524,4660248104095453669" class="gsc_a_ac gs_ibl">5912</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute&nbsp;…</a><div class="gs_gray">Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ...</div><div class="gs_gray">European heart journal 32 (23), 2999-3054<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10940886091574934766" class="gsc_a_ac gs_ibl">4579</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:HGTzPopzzJcC" class="gsc_a_at">2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS</a><div class="gs_gray">M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ...</div><div class="gs_gray">European journal of cardio-thoracic surgery 53 (1), 34-78<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11168392008785632019,3117681619763245455,11550654369236195048,14295339773525479400,6565992669787596960,9181242753609789726,2613835676551660345,2032953872654178874,7914901048939959690,13436084312648873762,14828383533401509717" class="gsc_a_ac gs_ibl">2191</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="-plVGtcAAAAJ:HGTzPopzzJcC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:ymY9cBF3mdcC" class="gsc_a_at">2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the Task Force for the diagnosis and management of chronic coronary syndromes of the&nbsp;…</a><div class="gs_gray">J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ...</div><div class="gs_gray">European heart journal 41 (3), 407-477<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14049156753241189371,15987809043505930297" class="gsc_a_ac gs_ibl">2050</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Long-term use of ticagrelor in patients with prior myocardial infarction</a><div class="gs_gray">MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...</div><div class="gs_gray">New England Journal of Medicine 372 (19), 1791-1800<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14637560597084070167" class="gsc_a_ac gs_ibl">1636</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the&nbsp;…</a><div class="gs_gray">PA Gurbel, KP Bliden, K Butler, US Tantry, T Gesheff, C Wei, R Teng, ...</div><div class="gs_gray">Circulation 120 (25), 2577-2585<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7865740217034798606" class="gsc_a_ac gs_ibl">1301</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:c1e4I3QdEKYC" class="gsc_a_at">ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European&nbsp;…</a><div class="gs_gray">AL Catapano, Ž Reiner, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">Atherosclerosis 217, 1-44<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8171058042899328801" class="gsc_a_ac gs_ibl">1014</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:ukw-9cB-YDkC" class="gsc_a_at">2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute&nbsp;…</a><div class="gs_gray">JP Collet, H Thiele, E Barbato, O Barthélémy, J Bauersachs, DL Bhatt, ...</div><div class="gs_gray">European heart journal 42 (14), 1289-1367<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9273248016312257174,4168065129136550036" class="gsc_a_ac gs_ibl">861</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the&nbsp;…</a><div class="gs_gray">L Wallentin, S James, RF Storey, M Armstrong, BJ Barratt, J Horrow, ...</div><div class="gs_gray">The Lancet 376 (9749), 1320-1328<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17060034004937053384" class="gsc_a_ac gs_ibl">822</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">Thrombin-receptor antagonist vorapaxar in acute coronary syndromes</a><div class="gs_gray">P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ...</div><div class="gs_gray">New England Journal of Medicine 366 (1), 20-33<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14379240396474234873" class="gsc_a_ac gs_ibl">774</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study</a><div class="gs_gray">CP Cannon, RA Harrington, S James, D Ardissino, RC Becker, ...</div><div class="gs_gray">The Lancet 375 (9711), 283-293<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3065212359451307124" class="gsc_a_ac gs_ibl">755</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:t-hv7AR41mYC" class="gsc_a_at">Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation</a><div class="gs_gray">RD Lopes, G Heizer, R Aronson, AN Vora, T Massaro, R Mehran, ...</div><div class="gs_gray">New England Journal of Medicine 380 (16), 1509-1524<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1107575866797618893" class="gsc_a_ac gs_ibl">616</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non–ST&nbsp;…</a><div class="gs_gray">CP Cannon, S Husted, RA Harrington, BM Scirica, H Emanuelsson, ...</div><div class="gs_gray">Journal of the American College of Cardiology 50 (19), 1844-1851<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8663558394657670008" class="gsc_a_ac gs_ibl">612</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a&nbsp;…</a><div class="gs_gray">Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ...</div><div class="gs_gray">European heart journal 35 (45), 3155-3179<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=468530388157466227" class="gsc_a_ac gs_ibl">609</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study</a><div class="gs_gray">PA Gurbel, KP Bliden, K Butler, MJ Antonino, C Wei, R Teng, ...</div><div class="gs_gray">Circulation 121 (10), 1188-1199<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14379172571341178374" class="gsc_a_ac gs_ibl">605</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient&nbsp;…</a><div class="gs_gray">C Held, N Åsenblad, JP Bassand, RC Becker, CP Cannon, MJ Claeys, ...</div><div class="gs_gray">Journal of the American College of Cardiology 57 (6), 672-684<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2184155473811901161" class="gsc_a_ac gs_ibl">595</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;citation_for_view=-plVGtcAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Prehospital ticagrelor in ST-segment elevation myocardial infarction</a><div class="gs_gray">G Montalescot, AW Van't Hof, F Lapostolle, J Silvain, JF Lassen, ...</div><div class="gs_gray">New England Journal of Medicine 371 (11), 1016-1027<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15365684360684124789" class="gsc_a_ac gs_ibl">572</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet&nbsp;…</a><div class="gs_gray">PG Steg, S James, RA Harrington, D Ardissino, RC Becker, CP Cannon, ...</div><div class="gs_gray">Circulation 122 (21), 2131-2141<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17812802185517277751" class="gsc_a_ac gs_ibl">569</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y<sub>12</sub>Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary&nbsp;…</a><div class="gs_gray">RF Storey, S Husted, RA Harrington, S Heptinstall, RG Wilcox, G Peters, ...</div><div class="gs_gray">Journal of the American College of Cardiology 50 (19), 1852-1856<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17794077491675777727" class="gsc_a_ac gs_ibl">541</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Expert position paper on air pollution and cardiovascular disease</a><div class="gs_gray">DE Newby, PM Mannucci, GS Tell, AA Baccarelli, RD Brook, K Donaldson, ...</div><div class="gs_gray">European heart journal 36 (2), 83-93<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4589742112670452699" class="gsc_a_ac gs_ibl">500</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial</a><div class="gs_gray">S James, DJ Angiolillo, JH Cornel, D Erlinge, S Husted, F Kontny, J Maya, ...</div><div class="gs_gray">European heart journal 31 (24), 3006-3016<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11941279698650104366" class="gsc_a_ac gs_ibl">460</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:ufrVoPGSRksC" class="gsc_a_at">Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline&nbsp;…</a><div class="gs_gray">S James, A Åkerblom, CP Cannon, H Emanuelsson, S Husted, H Katus, ...</div><div class="gs_gray">American heart journal 157 (4), 599-605<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13685695700666565222" class="gsc_a_ac gs_ibl">458</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial</a><div class="gs_gray">S James, A Budaj, P Aylward, KK Buck, CP Cannon, JH Cornel, ...</div><div class="gs_gray">Circulation 122 (11), 1056-1067<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14898619472284656849" class="gsc_a_ac gs_ibl">457</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for&nbsp;…</a><div class="gs_gray">M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...</div><div class="gs_gray">Eur Heart J 37 (3), 267-315<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3518039803537885993" class="gsc_a_ac gs_ibl">451</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:UebtZRa9Y70C" class="gsc_a_at">ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of&nbsp;…</a><div class="gs_gray">European Association for Cardiovascular Prevention &amp; Rehabilitation, ...</div><div class="gs_gray">Eur Heart J 32 (14), 1769-818<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16913274827700180157" class="gsc_a_ac gs_ibl">447</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial</a><div class="gs_gray">KW Mahaffey, DM Wojdyla, K Carroll, RC Becker, RF Storey, DJ Angiolillo, ...</div><div class="gs_gray">Circulation 124 (5), 544-554<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5727178218706082238" class="gsc_a_ac gs_ibl">428</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:0EnyYjriUFMC" class="gsc_a_at">Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes&nbsp;…</a><div class="gs_gray">RF Storey, DJ Angiolillo, SB Patil, B Desai, R Ecob, S Husted, ...</div><div class="gs_gray">Journal of the American College of Cardiology 56 (18), 1456-1462<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16554133046758723270" class="gsc_a_ac gs_ibl">406</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Bleeding complications with the P<sub>2</sub>Y<sub>12</sub> receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial</a><div class="gs_gray">RC Becker, JP Bassand, A Budaj, DM Wojdyla, SK James, JH Cornel, ...</div><div class="gs_gray">European heart journal 32 (23), 2933-2944<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14807304880506244881,17465753774295539516" class="gsc_a_ac gs_ibl">369</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">The role of platelets in inflammation</a><div class="gs_gray">MR Thomas, RF Storey</div><div class="gs_gray">Thrombosis and haemostasis 114 (09), 449-458<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1998618301764452898" class="gsc_a_ac gs_ibl">351</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and&nbsp;…</a><div class="gs_gray">SK James, MT Roe, CP Cannon, JH Cornel, J Horrow, S Husted, H Katus, ...</div><div class="gs_gray">Bmj 342<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8110862565522630350" class="gsc_a_ac gs_ibl">339</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:x21FZCSn4ZoC" class="gsc_a_at">Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label&nbsp;…</a><div class="gs_gray">G Montalescot, U Zeymer, J Silvain, B Boulanger, M Cohen, P Goldstein, ...</div><div class="gs_gray">The Lancet 378 (9792), 693-703<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18426337420979380372" class="gsc_a_ac gs_ibl">325</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:nPTYJWkExTIC" class="gsc_a_at">Complete revascularization with multivessel PCI for myocardial infarction</a><div class="gs_gray">SR Mehta, DA Wood, RF Storey, R Mehran, KR Bainey, H Nguyen, ...</div><div class="gs_gray">New England Journal of Medicine 381 (15), 1411-1421<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14292751321913681624" class="gsc_a_ac gs_ibl">324</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:5nxA0vEk-isC" class="gsc_a_at">The central role of the P<sub><i>2T</i></sub> receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity</a><div class="gs_gray">RF Storey, HM Sanderson, AE White, JA May, KE Cameron, S Heptinstall</div><div class="gs_gray">British journal of haematology 110 (4), 925-934<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6641043940558285161" class="gsc_a_ac gs_ibl">311</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention</a><div class="gs_gray">D Aradi, RF Storey, A Komócsi, D Trenk, D Gulba, RG Kiss, S Husted, ...</div><div class="gs_gray">European heart journal 35 (4), 209-215<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=931186375182549499" class="gsc_a_ac gs_ibl">300</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease</a><div class="gs_gray">MP Bonaca, DL Bhatt, RF Storey, PG Steg, M Cohen, J Kuder, E Goodrich, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (23), 2719-2728<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3374671250287058278" class="gsc_a_ac gs_ibl">294</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial</a><div class="gs_gray">D Lindholm, C Varenhorst, CP Cannon, RA Harrington, A Himmelmann, ...</div><div class="gs_gray">European heart journal 35 (31), 2083-2093<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4963161829982520023,1293532578585125012" class="gsc_a_ac gs_ibl">281</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="-plVGtcAAAAJ:JoZmwDi-zQgC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Antiplatelet agents for the treatment and prevention of atherothrombosis</a><div class="gs_gray">C Patrono, F Andreotti, H Arnesen, L Badimon, C Baigent, JP Collet, ...</div><div class="gs_gray">European heart journal 32 (23), 2922-2932<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8017605230313193247" class="gsc_a_ac gs_ibl">274</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:uVUOdF_882EC" class="gsc_a_at">International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptor–Inhibiting Therapies</a><div class="gs_gray">DJ Angiolillo, F Rollini, RF Storey, DL Bhatt, S James, DJ Schneider, ...</div><div class="gs_gray">Circulation 136 (20), 1955-1975<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1806276651743284956" class="gsc_a_ac gs_ibl">255</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes</a><div class="gs_gray">RF Storey, KG Oldroyd, RG Wilcox</div><div class="gs_gray">Thrombosis and haemostasis 85 (03), 401-407<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6780224972119038201" class="gsc_a_ac gs_ibl">241</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes</a><div class="gs_gray">RF Storey, RC Becker, RA Harrington, S Husted, SK James, F Cools, ...</div><div class="gs_gray">European heart journal 32 (23), 2945-2953<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11059488355302044152" class="gsc_a_ac gs_ibl">215</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Update on lipids, inflammation and atherothrombosis</a><div class="gs_gray">L Badimon, RF Storey, G Vilahur</div><div class="gs_gray">Thrombosis and haemostasis 105 (S 06), S34-S42<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12524218137182362853" class="gsc_a_ac gs_ibl">214</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial</a><div class="gs_gray">S Husted, S James, RC Becker, J Horrow, H Katus, RF Storey, ...</div><div class="gs_gray">Circulation: Cardiovascular Quality and Outcomes 5 (5), 680-688<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10729345054284840230" class="gsc_a_ac gs_ibl">212</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:_kc_bZDykSQC" class="gsc_a_at">First Analysis of the Relation Between <i>CYP2C19</i> Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel: The ONSET/OFFSET&nbsp;…</a><div class="gs_gray">US Tantry, KP Bliden, C Wei, RF Storey, M Armstrong, K Butler, PA Gurbel</div><div class="gs_gray">Circulation: Cardiovascular Genetics 3 (6), 556-566<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7236872216657349323" class="gsc_a_ac gs_ibl">211</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET&nbsp;…</a><div class="gs_gray">RF Storey, KP Bliden, SB Patil, A Karunakaran, R Ecob, K Butler, R Teng, ...</div><div class="gs_gray">Journal of the American College of Cardiology 56 (3), 185-193<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15945442640155625920" class="gsc_a_ac gs_ibl">200</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">PLATelet inhibition and patient Outcomes Investigators. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes&nbsp;…</a><div class="gs_gray">CP Cannon, RA Harrington, S James, D Ardissino, RC Becker, ...</div><div class="gs_gray">Lancet 375 (9711), 283-293<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1450637836012157202" class="gsc_a_ac gs_ibl">199</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Biology and pharmacology of the platelet P2Y12 receptor</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Current pharmaceutical design 12 (10), 1255-1259<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15085491577436051372" class="gsc_a_ac gs_ibl">199</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial</a><div class="gs_gray">SG Goodman, R Clare, KS Pieper, JC Nicolau, RF Storey, WJ Cantor, ...</div><div class="gs_gray">Circulation 125 (8), 978-986<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1212752552483426331" class="gsc_a_ac gs_ibl">196</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin</a><div class="gs_gray">RF Storey, HM Judge, RG Wilcox, S Heptinstall</div><div class="gs_gray">Thrombosis and haemostasis 88 (09), 488-494<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10125443673740424457" class="gsc_a_ac gs_ibl">196</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">2018 joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing&nbsp;…</a><div class="gs_gray">GYH Lip, JP Collet, M Haude, R Byrne, EH Chung, L Fauchier, ...</div><div class="gs_gray">Ep Europace 21 (2), 192-193<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17348873525915806220" class="gsc_a_ac gs_ibl">195</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:hMod-77fHWUC" class="gsc_a_at">Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis</a><div class="gs_gray">F Andreotti, B Rocca, S Husted, RA Ajjan, J Ten Berg, M Cattaneo, ...</div><div class="gs_gray">European heart journal 36 (46), 3238-3249<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3470331808602907992" class="gsc_a_ac gs_ibl">192</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:OzeSX8-yOCQC" class="gsc_a_at">Updated Expert Consensus Statement on Platelet Function and Genetic Testing for&nbsp;Guiding P2Y<sub>12</sub> Receptor Inhibitor Treatment in Percutaneous Coronary&nbsp;…</a><div class="gs_gray">D Sibbing, D Aradi, D Alexopoulos, J Ten Berg, DL Bhatt, L Bonello, ...</div><div class="gs_gray">JACC: Cardiovascular Interventions 12 (16), 1521-1537<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13079958389860470019" class="gsc_a_ac gs_ibl">190</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS–TIMI 54</a><div class="gs_gray">DL Bhatt, MP Bonaca, S Bansilal, DJ Angiolillo, M Cohen, RF Storey, K Im, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (23), 2732-2740<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17175712340227344251" class="gsc_a_ac gs_ibl">187</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease</a><div class="gs_gray">RF Storey, RG Wilcox, S Heptinstall</div><div class="gs_gray">Platelets 13 (7), 407-413<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17413763876127354454" class="gsc_a_ac gs_ibl">181</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel</a><div class="gs_gray">S Husted, R de Caterina, F Andreotti, H Arnesen, F Bachmann, K Huber, ...</div><div class="gs_gray">Thrombosis and haemostasis 112 (05), 781-782<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5688076828225222007" class="gsc_a_ac gs_ibl">179</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:IWHjjKOFINEC" class="gsc_a_at">Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial</a><div class="gs_gray">PG Steg, RA Harrington, H Emanuelsson, HA Katus, KW Mahaffey, ...</div><div class="gs_gray">Circulation 128 (10), 1055-1065<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13307715477222168668" class="gsc_a_ac gs_ibl">170</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy</a><div class="gs_gray">S Agewall, M Cattaneo, JP Collet, F Andreotti, GYH Lip, FWA Verheugt, ...</div><div class="gs_gray">European heart journal 34 (23), 1708-1713<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10176807663010320750" class="gsc_a_ac gs_ibl">166</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:dhFuZR0502QC" class="gsc_a_at">Agonists of toll-like receptor (TLR) 2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor</a><div class="gs_gray">JR Ward, L Bingle, HM Judge, SB Brown, RF Storey, MKB Whyte, ...</div><div class="gs_gray">Thrombosis and haemostasis 94 (10), 831-838<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8588345320930855079" class="gsc_a_ac gs_ibl">163</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:4DMP91E08xMC" class="gsc_a_at">The P2Y 12 receptor as a therapeutic target in cardiovascular disease</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Platelets 12 (4), 197-209<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12102701102861037434" class="gsc_a_ac gs_ibl">157</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet&nbsp;…</a><div class="gs_gray">BM Scirica, CP Cannon, H Emanuelsson, EL Michelson, RA Harrington, ...</div><div class="gs_gray">Journal of the American College of Cardiology 57 (19), 1908-1916<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8304591394836690286" class="gsc_a_ac gs_ibl">153</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y<sub>12</sub> inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54</a><div class="gs_gray">MP Bonaca, DL Bhatt, PG Steg, RF Storey, M Cohen, K Im, ...</div><div class="gs_gray">European heart journal 37 (14), 1133-1142<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13026134155531758799" class="gsc_a_ac gs_ibl">151</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack</a><div class="gs_gray">SK James, RF Storey, NS Khurmi, S Husted, M Keltai, KW Mahaffey, ...</div><div class="gs_gray">Circulation 125 (23), 2914-2921<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8815871247347817420" class="gsc_a_ac gs_ibl">149</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Response Variability to P2Y<sub>12</sub> Receptor Inhibitors: Expectations and Reality</a><div class="gs_gray">JM Siller-Matula, D Trenk, K Schrör, M Gawaz, SD Kristensen, RF Storey, ...</div><div class="gs_gray">JACC: Cardiovascular Interventions 6 (11), 1111-1128<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=202643830206150140" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention</a><div class="gs_gray">D Capodanno, R Mehran, M Valgimigli, U Baber, S Windecker, P Vranckx, ...</div><div class="gs_gray">Nature Reviews Cardiology 15 (8), 480-496<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17710362815887658465" class="gsc_a_ac gs_ibl">137</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:4n0clTBhZ78C" class="gsc_a_at">ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic&nbsp;…</a><div class="gs_gray">J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ...</div><div class="gs_gray">Eur Heart J 41 (3), 14<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4696642996971830236" class="gsc_a_ac gs_ibl">136</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:mB3voiENLucC" class="gsc_a_at">Design and rationale for the prevention of cardiovascular events in patients with prior heart attack using ticagrelor compared to placebo on a background of aspirin&nbsp;…</a><div class="gs_gray">MP Bonaca, DL Bhatt, E Braunwald, M Cohen, PG Steg, RF Storey, ...</div><div class="gs_gray">American heart journal 167 (4), 437-444. e5<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16898016464096980990" class="gsc_a_ac gs_ibl">135</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study</a><div class="gs_gray">RF Storey, SK James, A Siegbahn, C Varenhorst, C Held, J Ycas, ...</div><div class="gs_gray">Platelets 25 (7), 517-525<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4523073047928954987" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:-f6ydRqryjwC" class="gsc_a_at">ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task&nbsp;…</a><div class="gs_gray">CW Hamm, JP Bassand, S Agewall, J Bax, E Boersma, H Bueno, P Caso, ...</div><div class="gs_gray">Eur Heart J 32 (23), 2999-3054<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11704547123693822713" class="gsc_a_ac gs_ibl">133</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:RuPIJ_LgqDgC" class="gsc_a_at">PLATO investigators. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a&nbsp;…</a><div class="gs_gray">L Wallentin, S James, RF Storey, M Armstrong, BJ Barratt, J Horrow, ...</div><div class="gs_gray">Lancet 376 (9749), 1320-1328<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13662196827000916176" class="gsc_a_ac gs_ibl">132</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:P5F9QuxV20EC" class="gsc_a_at">Association of microRNAs and YRNAs with platelet function</a><div class="gs_gray">D Kaudewitz, P Skroblin, LH Bender, T Barwari, P Willeit, R Pechlaner, ...</div><div class="gs_gray">Circulation research 118 (3), 420-432<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5272315252153631337" class="gsc_a_ac gs_ibl">130</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Effects of P2Y 1 and P2Y 12 receptor antagonists on platelet aggregation induced by different agonists in human whole blood</a><div class="gs_gray">RF Storey, LJ Newby, S Heptinstall</div><div class="gs_gray">Platelets 12 (7), 443-447<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15620287011202828375" class="gsc_a_ac gs_ibl">128</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">PEGASUS-TIMI 54 Steering Committee and Investigators</a><div class="gs_gray">MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...</div><div class="gs_gray">Long-term use of ticagrelor in patients with prior myocardial infarction. N&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1387220197357432532" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of&nbsp;…</a><div class="gs_gray">S Halvorsen, RF Storey, B Rocca, D Sibbing, J Ten Berg, EL Grove, ...</div><div class="gs_gray">European Heart Journal 38 (19), 1455-1462<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10632701218311252291" class="gsc_a_ac gs_ibl">121</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Antiplatelet agents for the treatment and prevention of coronary atherothrombosis</a><div class="gs_gray">C Patrono, J Morais, C Baigent, JP Collet, D Fitzgerald, S Halvorsen, ...</div><div class="gs_gray">Journal of the American College of Cardiology 70 (14), 1760-1776<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16169186272459314222" class="gsc_a_ac gs_ibl">114</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:maZDTaKrznsC" class="gsc_a_at">Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST</a><div class="gs_gray">CW Hamm, JP Bassand, S Agewall, J Bax, E Boersma, H Bueno, P Caso, ...</div><div class="gs_gray">Revista Española de Cardiología 65 (2), 173. e1-173. e55<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1057785998515671341" class="gsc_a_ac gs_ibl">112</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the&nbsp;…</a><div class="gs_gray">Z Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">Eur Heart J 32 (14), 1769-1818<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6064570936605273905" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study</a><div class="gs_gray">E Hagström, SK James, M Bertilsson, RC Becker, A Himmelmann, ...</div><div class="gs_gray">European heart journal 37 (16), 1325-1333<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=97957059505450562" class="gsc_a_ac gs_ibl">107</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:jlhcAiayVhoC" class="gsc_a_at">Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo&nbsp;…</a><div class="gs_gray">DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ...</div><div class="gs_gray">The Lancet 394 (10204), 1169-1180<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11667396136444396019" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies</a><div class="gs_gray">KP Bliden, US Tantry, RF Storey, YH Jeong, M Gesheff, C Wei, PA Gurbel</div><div class="gs_gray">American heart journal 162 (1), 160-165<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12874050715558504121" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:hC7cP41nSMkC" class="gsc_a_at">Common sequence variations in the P2Y<sub>12</sub> and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy</a><div class="gs_gray">SMG Smith, HM Judge, G Peters, M Armstrong, P Fontana, P Gaussem, ...</div><div class="gs_gray">Platelets 17 (4), 250-258<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18414080723260347190" class="gsc_a_ac gs_ibl">103</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:u9iWguZQMMsC" class="gsc_a_at">Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial</a><div class="gs_gray">RF Storey, DJ Angiolillo, MP Bonaca, MR Thomas, HM Judge, F Rollini, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (10), 1145-1154<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2147222405845712489" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:vbGhcppDl1QC" class="gsc_a_at">ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute&nbsp;…</a><div class="gs_gray">CW Hamm, JP Bassand, S Agewall, J Bax, E Boersma, H Bueno, P Caso, ...</div><div class="gs_gray">Giornale italiano di cardiologia (2006) 13 (3), 171-228<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3437507330756642850,4183796543709924761" class="gsc_a_ac gs_ibl gsc_a_acm" data-eid="-plVGtcAAAAJ:vbGhcppDl1QC" data-eud="-plVGtcAAAAJ:D_sINldO8mEC">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:D_sINldO8mEC" class="gsc_a_at">ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute&nbsp;…</a><div class="gs_gray">CW Hamm, JP Bassand, S Agewall, J Bax, E Boersma, H Bueno, P Caso, ...</div><div class="gs_gray">Giornale italiano di cardiologia (2006) 13 (3), 171-228<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3437507330756642850,4183796543709924761" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in Non–ST-Elevation acute coronary syndrome patients managed with or without in-hospital&nbsp;…</a><div class="gs_gray">L Wallentin, D Lindholm, A Siegbahn, L Wernroth, RC Becker, ...</div><div class="gs_gray">Circulation 129 (3), 293-303<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14664792697682772080" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study</a><div class="gs_gray">P Kohli, L Wallentin, E Reyes, J Horrow, S Husted, DJ Angiolillo, ...</div><div class="gs_gray">Circulation 127 (6), 673-680<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18209820735376341906" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:TQgYirikUcIC" class="gsc_a_at">Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery</a><div class="gs_gray">C Varenhorst, U Alström, BM Scirica, CW Hogue, N Åsenblad, RF Storey, ...</div><div class="gs_gray">Journal of the American College of Cardiology 60 (17), 1623-1630<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4415592634875445410" class="gsc_a_ac gs_ibl">99</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial</a><div class="gs_gray">G Magnani, RF Storey, G Steg, DL Bhatt, M Cohen, J Kuder, K Im, ...</div><div class="gs_gray">European heart journal 37 (4), 400-408<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11673327816623495973" class="gsc_a_ac gs_ibl">98</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute&nbsp;…</a><div class="gs_gray">CW Hamm, JP Bassand, S Agewall, J Bax, E Boersma, H Bueno, P Caso, ...</div><div class="gs_gray">Giornale italiano di cardiologia (2006) 13 (3), 171-228<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3437507330756642850" class="gsc_a_ac gs_ibl gsc_a_acm" data-eid="-plVGtcAAAAJ:e5wmG9Sq2KIC" data-eud="-plVGtcAAAAJ:D_sINldO8mEC">98</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function</a><div class="gs_gray">HM Judge, RJ Buckland, A Sugidachi, JA Jakubowski, RF Storey</div><div class="gs_gray">Thrombosis and haemostasis 103 (06), 1210-1217<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2579168529983897977" class="gsc_a_ac gs_ibl">93</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Aspirin resistance and diabetes mellitus</a><div class="gs_gray">R Ajjan, RF Storey, PJ Grant</div><div class="gs_gray">Diabetologia 51 (3), 385-390<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15219326459457622459" class="gsc_a_ac gs_ibl">93</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction</a><div class="gs_gray">J Silvain, RF Storey, G Cayla, JB Esteve, JG Dillinger, H Rousseau, ...</div><div class="gs_gray">Thrombosis and haemostasis 116 (08), 369-378<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8796635604592084013" class="gsc_a_ac gs_ibl">92</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function&nbsp;…</a><div class="gs_gray">RF Storey, RC Becker, RA Harrington, S Husted, SK James, F Cools, ...</div><div class="gs_gray">The American journal of cardiology 108 (11), 1542-1546<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7000232825731002594" class="gsc_a_ac gs_ibl">91</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:geHnlv5EZngC" class="gsc_a_at">Platelet P2Y<sub>12</sub> Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model</a><div class="gs_gray">MR Thomas, SN Outteridge, RA Ajjan, F Phoenix, GK Sangha, ...</div><div class="gs_gray">Arteriosclerosis, thrombosis, and vascular biology 35 (12), 2562-2570<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=804140290815093546" class="gsc_a_ac gs_ibl">90</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:UxriW0iASnsC" class="gsc_a_at">Effect of genetic variations on ticagrelor plasma levels and clinical outcomes</a><div class="gs_gray">C Varenhorst, N Eriksson, Å Johansson, BJ Barratt, E Hagström, ...</div><div class="gs_gray">European heart journal 36 (29), 1901-1912<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6083396718494590627" class="gsc_a_ac gs_ibl">89</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: data from the PLATO Trial</a><div class="gs_gray">MR Patel, RC Becker, DM Wojdyla, H Emanuelsson, WR Hiatt, J Horrow, ...</div><div class="gs_gray">European journal of preventive cardiology 22 (6), 734-742<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6913315884817351256" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease</a><div class="gs_gray">D Kaudewitz, R Lee, P Willeit, R McGregor, HS Markus, S Kiechl, ...</div><div class="gs_gray">Thrombosis and haemostasis 110 (09), 609-615<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6173408155169595766" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">European Association for Cardiovascular Prevention and Rehabilitation; ESC Heart Failure Association. Expert position paper on air pollution and cardiovascular disease</a><div class="gs_gray">DE Newby, PM Mannucci, GS Tell, AA Baccarelli, RD Brook, K Donaldson, ...</div><div class="gs_gray">Eur Heart J 36 (2), 83-93b<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18047847517411352460" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=-plVGtcAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency&nbsp;…</a><div class="gs_gray">RF Storey, RG Wilcox, S Heptinstall</div><div class="gs_gray">Circulation 98 (16), 1616-1621<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3665278112359204863" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy</a><div class="gs_gray">W Sumaya, L Wallentin, SK James, A Siegbahn, K Gabrysch, M Bertilsson, ...</div><div class="gs_gray">European heart journal 39 (13), 1078-1085<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8565325298582782145" class="gsc_a_ac gs_ibl">85</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:k_IJM867U9cC" class="gsc_a_at">Platelet P2Y<sub>12</sub> Receptor Influences the Vessel Wall Response to Arterial Injury and Thrombosis</a><div class="gs_gray">DJW Evans, LE Jackman, J Chamberlain, DJ Crosdale, HM Judge, ...</div><div class="gs_gray">Circulation 119 (1), 116-122<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16322250902950611604" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:eflP2zaiRacC" class="gsc_a_at">Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST: Grupo de Trabajo de la Sociedad Europea de&nbsp;…</a><div class="gs_gray">M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...</div><div class="gs_gray">Revista española de cardiología 68 (12), 1125. e1-1125. e64<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15123601849208191464" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BqipwSGYUEgC" class="gsc_a_at">Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease</a><div class="gs_gray">SE Husted, RF Storey, K Bliden, US Tantry, L Høimark, K Butler, C Wei, ...</div><div class="gs_gray">Clinical pharmacokinetics 51 (6), 397-409<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8452772178315418185,8702122960684346893" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:oTdOBqtIf_kC" class="gsc_a_at">Information processing apparatus, program and coordinate input method</a><div class="gs_gray">S Kawano, M Nakano, Y Ohmori</div><div class="gs_gray">US Patent 6,992,660<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3040880667983893391,3658736395661783407" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Thrombosis and haemostasis 105 (S 06), S75-S81<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4554084201875200479" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Long-term tolerability of ticagrelor for the secondary prevention of major adverse cardiovascular events: a secondary analysis of the PEGASUS-TIMI 54 trial</a><div class="gs_gray">MP Bonaca, DL Bhatt, TO Ophuis, PG Steg, R Storey, M Cohen, J Kuder, ...</div><div class="gs_gray">JAMA cardiology 1 (4), 425-432<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=307869059211573520" class="gsc_a_ac gs_ibl">79</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:U_HPUtbDl20C" class="gsc_a_at">Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European&nbsp;…</a><div class="gs_gray">GYH Lip, JP Collet, R Caterina, L Fauchier, DA Lane, TB Larsen, F Marin, ...</div><div class="gs_gray">Ep Europace 19 (11), 1757-1758<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3253056416077963038" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery</a><div class="gs_gray">M Sousa-Uva, R Storey, K Huber, V Falk, AF Leite-Moreira, J Amour, ...</div><div class="gs_gray">European heart journal 35 (23), 1510-1514<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9338662210531867439" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12&nbsp;…</a><div class="gs_gray">RF Storey, S Melissa Thornton, R Lawrance, S Husted, M Wickens, ...</div><div class="gs_gray">Platelets 20 (5), 341-348<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=152821774774379138" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses</a><div class="gs_gray">RF Storey, KP Bliden, R Ecob, A Karunakaran, K Butler, C Wei, U Tantry, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 9 (9), 1730-1737<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3129652694987342374" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Effect of P2Y12 inhibitors on inflammation and immunity</a><div class="gs_gray">MR Thomas, RF Storey</div><div class="gs_gray">Thrombosis and haemostasis 114 (09), 490-497<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3527848817467589109" class="gsc_a_ac gs_ibl">70</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting</a><div class="gs_gray">J Iqbal, W Sumaya, V Tatman, Y Parviz, AC Morton, ED Grech, ...</div><div class="gs_gray">EuroIntervention 9 (1), 62-69<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12627274963283654209" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Antiplatelet therapy in cardiovascular disease</a><div class="gs_gray">MWH Behan, RF Storey</div><div class="gs_gray">Postgraduate medical journal 80 (941), 155-164<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2337991661489849217" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BW2nPTmhBn4C" class="gsc_a_at">ESC/EAS Guidelines for the management of dyslipidaemias</a><div class="gs_gray">AL Catapano, Ž Reiner, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">Atherosclerosis 1 (217), 3-46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3796760722543523154" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non–ST-elevation acute coronary syndromes: results from&nbsp;…</a><div class="gs_gray">A Åkerblom, L Wallentin, A Siegbahn, RC Becker, A Budaj, K Buck, ...</div><div class="gs_gray">Clinical chemistry 58 (1), 190-199<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12805426730272124279" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">The active metabolite of prasugrel effectively blocks the platelet P2Y<sub>12</sub> receptor and inhibits procoagulant and pro-inflammatory platelet responses</a><div class="gs_gray">HM Judge, RJ Buckland, A Sugidachi, JA Jakubowski, RF Storey</div><div class="gs_gray">Platelets 19 (2), 125-133<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14774520223358351733" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial</a><div class="gs_gray">S Husted, SK James, RG Bach, RC Becker, A Budaj, M Heras, ...</div><div class="gs_gray">European heart journal 35 (23), 1541-1550<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7100302127624546242" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Comparison of two strategies for the management of antiplatelet therapy during urgent surgery</a><div class="gs_gray">E Akowuah, V Shrivastava, B Jamnadas, D Hopkinson, P Sarkar, R Storey, ...</div><div class="gs_gray">The Annals of thoracic surgery 80 (1), 149-152<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6146904192142630429" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis</a><div class="gs_gray">B Rocca, KAA Fox, RA Ajjan, F Andreotti, C Baigent, JP Collet, EL Grove, ...</div><div class="gs_gray">European heart journal 39 (19), 1672-1686f<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5932193236582881228" class="gsc_a_ac gs_ibl">65</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review</a><div class="gs_gray">WJM Dewilde, PWA Janssen, FWA Verheugt, RF Storey, T Adriaenssens, ...</div><div class="gs_gray">Journal of the American College of Cardiology 64 (12), 1270-1280<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15664516379163327299" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:GnPB-g6toBAC" class="gsc_a_at">Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—insights from the PLATelet inhibition and patient&nbsp;…</a><div class="gs_gray">JH Cornel, RC Becker, SG Goodman, S Husted, H Katus, A Santoso, ...</div><div class="gs_gray">American heart journal 164 (3), 334-342. e1<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11826989160211704588" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:M05iB0D1s5AC" class="gsc_a_at">Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel</a><div class="gs_gray">S Husted, RF Storey, RA Harrington, H Emanuelsson, CP Cannon</div><div class="gs_gray">Clinical Cardiology: An International Indexed and Peer‐Reviewed Journal for&nbsp;…<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12201606519689457054" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Dyspnoea management in acute coronary syndrome patients treated with ticagrelor</a><div class="gs_gray">G Parodi, RF Storey</div><div class="gs_gray">European Heart Journal: Acute Cardiovascular Care 4 (6), 555-560<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4135266247223578878" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Guía de la ESC/EAS sobre el manejo de las dislipemias</a><div class="gs_gray">Ž Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">Revista Española de Cardiología 64 (12), 1168. e1-1168. e60<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2585371060389297953,12434911109227638036,16457958886113052071,8483422665832218828" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sszUF3NjhM4C" class="gsc_a_at">Efficacy and safety of ticagrelor over time in patients with prior MI in PEGASUS-TIMI 54</a><div class="gs_gray">MP Bonaca, RF Storey, P Theroux, PG Steg, DL Bhatt, MC Cohen, KA Im, ...</div><div class="gs_gray">Journal of the American College of Cardiology 70 (11), 1368-1375<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12807193080382538038" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:738O_yMBCRsC" class="gsc_a_at">Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention</a><div class="gs_gray">MA Velders, J Abtan, DJ Angiolillo, D Ardissino, RA Harrington, ...</div><div class="gs_gray">Heart 102 (8), 617-625<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15900077512865818870" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yD5IFk8b50cC" class="gsc_a_at">Association of spontaneous and procedure-related bleeds with short-and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial.</a><div class="gs_gray">G Ducrocq, PJ Schulte, RC Becker, CP Cannon, RA Harrington, C Held, ...</div><div class="gs_gray">EuroIntervention: journal of EuroPCR in collaboration with the Working Group&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=607976847762817058" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy</a><div class="gs_gray">SMG Smith, HM Judge, G Peters, M Armstrong, A Dupont, P Gaussem, ...</div><div class="gs_gray">Platelets 16 (6), 340-345<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9649646785330966175" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yeL6HyUMUGUC" class="gsc_a_at">Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the AUGUSTUS trial</a><div class="gs_gray">RD Lopes, S Leonardi, DM Wojdyla, AN Vora, L Thomas, RF Storey, ...</div><div class="gs_gray">Circulation 141 (9), 781-783<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1969356450361611039" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease</a><div class="gs_gray">RC Orme, WAE Parker, MR Thomas, HM Judge, K Baster, W Sumaya, ...</div><div class="gs_gray">Circulation 138 (13), 1290-1300<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2276517742176863587" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position&nbsp;…</a><div class="gs_gray">A Niessner, J Tamargo, J Morais, L Koller, S Wassmann, SE Husted, ...</div><div class="gs_gray">European heart journal 38 (22), 1710-1716<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3892552952408756222" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4e5Qn2KL_jwC" class="gsc_a_at">The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS),“ESC/EAS Guidelines for the&nbsp;…</a><div class="gs_gray">AL Catapano, Z Reiner, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">Atherosclerosis 217 (1), 3-46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1625499021855360966" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction</a><div class="gs_gray">MR Thomas, AC Morton, R Hossain, B Chen, L Luo, NNBM Shahari, ...</div><div class="gs_gray">Thrombosis and haemostasis 116 (07), 96-102<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5167690435771089080" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Causes of mortality with ticagrelor compared with clopidogrel in acute coronary syndromes</a><div class="gs_gray">C Varenhorst, U Alström, OÖ Braun, RF Storey, KW Mahaffey, ...</div><div class="gs_gray">Heart 100 (22), 1762-1769<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2040630211151202489" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:35N4QoGY0k4C" class="gsc_a_at">Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for&nbsp;…</a><div class="gs_gray">DJ Whellan, P Tricoci, E Chen, Z Huang, D Leibowitz, P Vranckx, ...</div><div class="gs_gray">Journal of the American College of Cardiology 63 (11), 1048-1057<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2002464180682800804" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Glycoprotein IIb/IIIa and P2Y<sub>12</sub> receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant&nbsp;…</a><div class="gs_gray">HM Judge, RJ Buckland, CE Holgate, RF Storey</div><div class="gs_gray">Platelets 16 (7), 398-407<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13797414319012959486" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention</a><div class="gs_gray">SMG Smith, HM Judge, G Peters, RF Storey</div><div class="gs_gray">Platelets 15 (8), 465-474<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14115721195792830775" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: insights from EPICOR, an international study of&nbsp;…</a><div class="gs_gray">H Bueno, P Sinnaeve, L Annemans, N Danchin, M Licour, J Medina, ...</div><div class="gs_gray">European Heart Journal: Acute Cardiovascular Care 5 (1), 3-12<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11771458466599995633" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:u_35RYKgDlwC" class="gsc_a_at">How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors–is an algorithm the answer?</a><div class="gs_gray">JM Siller-Matula, D Trenk, K Schrör, M Gawaz, SD Kristensen, RF Storey, ...</div><div class="gs_gray">Thrombosis and haemostasis 113 (01), 37-52<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14782537691483616735" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial</a><div class="gs_gray">KW Mahaffey, C Held, DM Wojdyla, SK James, HA Katus, S Husted, ...</div><div class="gs_gray">Journal of the American College of Cardiology 63 (15), 1493-1499<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=435121926042312236" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet&nbsp;…</a><div class="gs_gray">MA Velders, L Wallentin, RC Becker, AJ van Boven, A Himmelmann, ...</div><div class="gs_gray">American heart journal 169 (6), 879-889. e7<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17565441741046322521" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Ticagrelor Effectively and Reversibly Blocks Murine Platelet P2Y<sub>12</sub>-Mediated Thrombosis and Demonstrates a Requirement for Sustained P2Y<sub>12</sub> Inhibition to&nbsp;…</a><div class="gs_gray">SB Patil, LE Jackman, SE Francis, HM Judge, S Nylander, RF Storey</div><div class="gs_gray">Arteriosclerosis, thrombosis, and vascular biology 30 (12), 2385-2391<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1723770385003073766" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:blknAaTinKkC" class="gsc_a_at">REVIEWLaboratory investigation of platelet function</a><div class="gs_gray">RF Storey, S Heptinstall</div><div class="gs_gray">Clinical &amp; Laboratory Haematology 21 (5), 317-329<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3371747178534760719" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:lg2tdxc6qMwC" class="gsc_a_at">Benefit and risks of aspirin in addition to ticagrelor in acute coronary syndromes: a post hoc analysis of the randomized GLOBAL LEADERS trial</a><div class="gs_gray">M Tomaniak, P Chichareon, Y Onuma, EN Deliargyris, K Takahashi, ...</div><div class="gs_gray">JAMA cardiology 4 (11), 1092-1101<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3506041071981934881" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:NhqRSupF_l8C" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with acute coronary syndromes and chronic obstructive pulmonary disease: an analysis from the Platelet Inhibition and Patient Outcomes&nbsp;…</a><div class="gs_gray">P Andell, SK James, CP Cannon, DD Cyr, A Himmelmann, S Husted, ...</div><div class="gs_gray">Journal of the American Heart Association 4 (10), e002490<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10526243692933446782" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:DkZNVXde3BIC" class="gsc_a_at">Ticagrelor for secondary prevention of atherothrombotic events in patients with multivessel coronary disease</a><div class="gs_gray">S Bansilal, MP Bonaca, JH Cornel, RF Storey, DL Bhatt, PG Steg, K Im, ...</div><div class="gs_gray">Journal of the American College of Cardiology 71 (5), 489-496<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6767329680062045629" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ldfaerwXgEUC" class="gsc_a_at">A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies</a><div class="gs_gray">RF Storey, JA May, RG Wilcox, S Heptinstall</div><div class="gs_gray">Thrombosis and haemostasis 82 (10), 1307-1311<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17675305365742381840" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Inhibitory effects of P2Y<sub>12</sub> receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium&nbsp;…</a><div class="gs_gray">MWH Behan, SC Fox, S Heptinstall, RF Storey</div><div class="gs_gray">Platelets 16 (2), 73-80<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11376974948138102997" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:wyM6WWKXmoIC" class="gsc_a_at">Timing of staged nonculprit artery revascularization in patients with ST-segment elevation myocardial infarction: COMPLETE trial</a><div class="gs_gray">DA Wood, JA Cairns, J Wang, R Mehran, RF Storey, H Nguyen, B Meeks, ...</div><div class="gs_gray">Journal of the American College of Cardiology 74 (22), 2713-2723<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3447417582485244646" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:RJOyoaXV5v8C" class="gsc_a_at">Effect of hypoglycemia on inflammatory responses and the response to low-dose endotoxemia in humans</a><div class="gs_gray">A Iqbal, LR Prince, P Novodvorsky, A Bernjak, MR Thomas, L Birch, ...</div><div class="gs_gray">The Journal of Clinical Endocrinology &amp; Metabolism 104 (4), 1187-1199<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12073958339687658788" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">Angiographic outcomes in the PLATO trial (Platelet Inhibition and Patient Outcomes)</a><div class="gs_gray">V Kunadian, SK James, DM Wojdyla, C Zorkun, J Wu, RF Storey, PG Steg, ...</div><div class="gs_gray">JACC: Cardiovascular Interventions 6 (7), 671-683<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10953590835456269528" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:70eg2SAEIzsC" class="gsc_a_at">Clopidogrel in acute coronary syndrome: to genotype or not?</a><div class="gs_gray">RF Storey</div><div class="gs_gray">The Lancet 373 (9660), 276-278<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16175638997477954969" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Platelet function testing in acute cardiac care–is there a role for prediction or prevention of stent thrombosis and bleeding?</a><div class="gs_gray">D Aradi, JP Collet, J Mair, M Plebani, B Merkely, AS Jaffe, M Möckel, ...</div><div class="gs_gray">Thrombosis and haemostasis 114 (02), 221-230<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1236726285610439575" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:rO6llkc54NcC" class="gsc_a_at">ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy</a><div class="gs_gray">PW Armstrong, H Siha, Y Fu, CM Westerhout, PG Steg, SK James, ...</div><div class="gs_gray">Circulation 125 (3), 514-521<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16928432060196467964" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:HE397vMXCloC" class="gsc_a_at">Prevention of stroke with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior&nbsp;…</a><div class="gs_gray">MP Bonaca, S Goto, DL Bhatt, PG Steg, RF Storey, M Cohen, E Goodrich, ...</div><div class="gs_gray">Circulation 134 (12), 861-871<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=886758308621373184" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:bnK-pcrLprsC" class="gsc_a_at">The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA• CER) trial: study design and rationale</a><div class="gs_gray">TRA The, CER Executive, S Committees</div><div class="gs_gray">American Heart Journal 158 (3), 327-334. e4<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13268574872068419542" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:TGkaJS32XoUC" class="gsc_a_at">Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease</a><div class="gs_gray">D Capodanno, DL Bhatt, JW Eikelboom, KAA Fox, T Geisler, CM Gibson, ...</div><div class="gs_gray">Nature Reviews Cardiology 17 (4), 242-257<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14310685971404073109" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis</a><div class="gs_gray">D Alexopoulos, I Xanthopoulou, RF Storey, KP Bliden, US Tantry, ...</div><div class="gs_gray">American heart journal 168 (4), 530-536<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2988171551267421957" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Vessel wall, not platelet, P2Y<sub>12</sub> potentiates early atherogenesis</a><div class="gs_gray">LE West, T Steiner, HM Judge, SE Francis, RF Storey</div><div class="gs_gray">Cardiovascular research 102 (3), 429-435<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1987429512419402676" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Management of Acute Coronary Syndromes in Patients Presenting without Persistent STSEotESoC. 2015 ESC Guidelines for the management of acute coronary syndromes in patients&nbsp;…</a><div class="gs_gray">M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...</div><div class="gs_gray">Eur Heart J 37 (3), 267-315<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4131062700344993650" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Association of multiple biomarkers with risk of all-cause and cause-specific mortality after acute coronary syndromes: a secondary analysis of the PLATO biomarker study</a><div class="gs_gray">D Lindholm, SK James, K Gabrysch, RF Storey, A Himmelmann, ...</div><div class="gs_gray">JAMA cardiology 3 (12), 1160-1166<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10344681856764520959" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Platelet function testing and prediction of procedural bleeding risk</a><div class="gs_gray">EL Grove, R Hossain, RF Storey</div><div class="gs_gray">Thrombosis and haemostasis 109 (05), 817-824<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3525574233248782583" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y<sub>12</sub> receptor blockade and inhibition of platelet aggregation after clopidogrel</a><div class="gs_gray">HM Judge, SB Patil, RJ Buckland, JA Jakubowski, RF Storey</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 8 (8), 1820-1827<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14894033151582654682" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:f2IySw72cVMC" class="gsc_a_at">Stabilizing role of platelet P2Y12 receptors in shear-dependent thrombus formation on ruptured plaques</a><div class="gs_gray">R Nergiz-Unal, JMEM Cosemans, MAH Feijge, PEJ van der Meijden, ...</div><div class="gs_gray">PLoS One 5 (4), e10130<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7619432153901248375" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome</a><div class="gs_gray">Å Johansson, N Eriksson, D Lindholm, C Varenhorst, S James, ...</div><div class="gs_gray">Human molecular genetics 25 (7), 1447-1456<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3165201852860771207" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-7ulzOJl1JYC" class="gsc_a_at">Platelet function testing in atherothrombotic disease</a><div class="gs_gray">E Lerkevang Grove, R F Storey, M Wurtz</div><div class="gs_gray">Current pharmaceutical design 18 (33), 5379-5391<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4629344548717010840" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Y5dfb0dijaUC" class="gsc_a_at">Effect of pre-hospital ticagrelor during the first 24 h after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: the&nbsp;…</a><div class="gs_gray">G Montalescot, AW van’t Hof, L Bolognese, WJ Cantor, A Cequier, ...</div><div class="gs_gray">JACC: Cardiovascular Interventions 9 (7), 646-656<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11029423464012853001,11731318344447502136" class="gsc_a_ac gs_ibl">34</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="-plVGtcAAAAJ:Y5dfb0dijaUC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">The DISPERSE2 trial: safety, tolerability and preliminary efficacy of AZD6140, the first oral reversible ADP receptor antagonist, compared with clopidogrel in patients with non&nbsp;…</a><div class="gs_gray">CP Cannon, S Husted, RF Storey, RA Harrington, S Hill, D Price, ...</div><div class="gs_gray">Circulation 112 (17), U677-U677<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4203910990882164606" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:rqnDXT1GswoC" class="gsc_a_at">Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione: Task Force per il&nbsp;…</a><div class="gs_gray">M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...</div><div class="gs_gray">Giornale italiano di cardiologia 17 (10), 831-872<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11348844930460065748" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Non-vitamin K antagonist oral anticoagulants (NOACs): clinical evidence and therapeutic considerations</a><div class="gs_gray">K Saraf, P Morris, P Garg, P Sheridan, R Storey</div><div class="gs_gray">Postgraduate medical journal 90 (1067), 520-528<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16032202790509000471" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes</a><div class="gs_gray">G Ducrocq, PJ Schulte, A Budaj, JH Cornel, C Held, A Himmelmann, ...</div><div class="gs_gray">American heart journal 186, 91-99<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9956470974939020281" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WzTVkKNmPSkC" class="gsc_a_at">Complete vs culprit-lesion-only revascularization for ST-segment elevation myocardial infarction: a systematic review and meta-analysis</a><div class="gs_gray">KR Bainey, T Engstrøm, PC Smits, AH Gershlick, SK James, RF Storey, ...</div><div class="gs_gray">JAMA cardiology 5 (8), 881-888<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4035846891324391874" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Current strategies in antiplatelet therapy—Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?</a><div class="gs_gray">T Geisler, M Gawaz, SR Steinhubl, DL Bhatt, RF Storey, M Flather</div><div class="gs_gray">Pharmacology &amp; therapeutics 127 (2), 95-107<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15691269030842785678" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin</a><div class="gs_gray">RF Storey, JA May, S Heptinstall</div><div class="gs_gray">Thrombosis research 115 (4), 301-307<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13507511053210927803" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sSrBHYA8nusC" class="gsc_a_at">Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial</a><div class="gs_gray">H Siha, D Das, Y Fu, Y Zheng, CM Westerhout, RF Storey, S James, ...</div><div class="gs_gray">Cmaj 184 (10), 1135-1142<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11346853191806601094" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:abG-DnoFyZgC" class="gsc_a_at">Antiplatelet therapy and vascular disease: an update</a><div class="gs_gray">MH Buch, BD Prendergast, RF Storey</div><div class="gs_gray">Therapeutic advances in cardiovascular disease 4 (4), 249-275<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3688777086479192025" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:a0OBvERweLwC" class="gsc_a_at">New developments in antiplatelet therapy</a><div class="gs_gray">RF Storey</div><div class="gs_gray">European heart journal supplements 10 (suppl_D), D30-D37<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7956706924322749056" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SpPTWFSNUtQC" class="gsc_a_at">Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography Substudys</a><div class="gs_gray">N Pinilla-Echeverri, SR Mehta, J Wang, S Lavi, E Schampaert, WJ Cantor, ...</div><div class="gs_gray">Circulation: Cardiovascular Interventions 13 (7), e008768<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16200825539117548850" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes</a><div class="gs_gray">RF Storey, J Kotha, SS Smyth, DJ Moliterno, TL Rorick, T Moccetti, ...</div><div class="gs_gray">Thrombosis and haemostasis 112 (05), 883-891<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10842569206301657682" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:dshw04ExmUIC" class="gsc_a_at">Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes—results from the PLATO trial</a><div class="gs_gray">LÅ Levin, L Wallentin, L Bernfort, D Andersson, RF Storey, G Bergström, ...</div><div class="gs_gray">Value in health 16 (4), 574-580<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4703510718021709478" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SP6oXDckpogC" class="gsc_a_at">Variability of response to antiplatelet therapy</a><div class="gs_gray">RF Storey</div><div class="gs_gray">European heart journal supplements 10 (suppl_A), A21-A27<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3201430537434085344" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Platelets: developmental biology, physiology, and translatable platforms for preclinical investigation and drug development</a><div class="gs_gray">NS Kleiman, JE Freedman, PB Tracy, BC Furie, PF Bray, SV Rao, ...</div><div class="gs_gray">Platelets 19 (4), 239-251<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10952586067711429016" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:H7nrzBkawXsC" class="gsc_a_at">Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y<sub>12</sub> receptor antagonist, in patients with&nbsp;…</a><div class="gs_gray">RF Storey, PA Gurbel, J Ten Berg, C Bernaud, GD Dangas, JM Frenoux, ...</div><div class="gs_gray">European heart journal 41 (33), 3132-3140<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1820874717036159914" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:as0KMg8qHbkC" class="gsc_a_at">Thrombo-inflammation in cardiovascular disease: an expert consensus document from the third Maastricht consensus conference on thrombosis</a><div class="gs_gray">E d’Alessandro, C Becker, W Bergmeier, C Bode, JH Bourne, H Brown, ...</div><div class="gs_gray">Thrombosis and haemostasis 120 (04), 538-564<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8045974211873655820" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Monitoring antiplatelet therapy</a><div class="gs_gray">R Orme, HM Judge, RF Storey</div><div class="gs_gray">Seminars in thrombosis and hemostasis 43 (03), 311-319<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7268210618175772474" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Effect of pre-hospital ticagrelor during the first 24 h after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: the&nbsp;…</a><div class="gs_gray">G Montalescot, AW van’t Hof, L Bolognese, WJ Cantor, A Cequier, ...</div><div class="gs_gray">JACC: Cardiovascular Interventions 9 (7), 646-656<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11029423464012853001" class="gsc_a_ac gs_ibl gsc_a_acm" data-eid="-plVGtcAAAAJ:AXPGKjj_ei8C" data-eud="-plVGtcAAAAJ:Y5dfb0dijaUC">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Cangrelor inhibits the binding of the active metabolites of clopidogrel and prasugrel to P2Y<sub>12</sub> receptors <i>in vitro</i></a><div class="gs_gray">HM Judge, RJ Buckland, JA Jakubowski, RF Storey</div><div class="gs_gray">Platelets 27 (3), 191-195<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1730972674870490635" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: Findings from the EPICOR study</a><div class="gs_gray">PR Sinnaeve, U Zeymer, H Bueno, N Danchin, J Medina, ...</div><div class="gs_gray">European Heart Journal: Acute Cardiovascular Care 4 (3), 254-262<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16966465132178205243" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Biomarkers and coronary lesions predict outcomes after revascularization in non–ST-elevation acute coronary syndrome</a><div class="gs_gray">D Lindholm, SK James, M Bertilsson, RC Becker, CP Cannon, ...</div><div class="gs_gray">Clinical chemistry 63 (2), 573-584<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3889216323318370879" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">Heart 102 (10), 783-789<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7225718704822945944" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact</a><div class="gs_gray">HM Judge, LK Jennings, DJ Moliterno, E Hord, R Ecob, P Tricoci, T Rorick, ...</div><div class="gs_gray">Platelets 26 (3), 236-242<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4262534830879296176" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Development and clinical use of prasugrel and ticagrelor</a><div class="gs_gray">S Ahmad, R F Storey</div><div class="gs_gray">Current pharmaceutical design 18 (33), 5240-5260<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3617627153058195715" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">Comparison of P2Y<sub>12</sub> inhibitors for mortality and stent thrombosis in patients with acute coronary syndromes: Single center study of 10 793 consecutive ‘real-world&nbsp;…</a><div class="gs_gray">R Gosling, M Yazdani, Y Parviz, IR Hall, ED Grech, JP Gunn, RF Storey, ...</div><div class="gs_gray">Platelets 28 (8), 767-773<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=163607038677877412" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis–Task Force on Anticoagulants in Heart Disease</a><div class="gs_gray">R De Caterina, S Husted, L Wallentin, F Andreotti, H Arnesen, ...</div><div class="gs_gray">Thrombosis and haemostasis 115 (04), 685-711<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10336009437609751708" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:DrR-2ekChdkC" class="gsc_a_at">Wytyczne ESC dotyczace postepowania w ostrych zespolach wiencowych bez przetrwalego uniesienia odcinka ST w 2015 roku.</a><div class="gs_gray">M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...</div><div class="gs_gray">Kardiologia polska 73 (12), 1207-94<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15469731352519118447" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Cystatin C–and Creatinine-Based Estimates of Renal Function and Their Value for Risk Prediction in Patients with Acute Coronary Syndrome: Results from the PLATelet Inhibition&nbsp;…</a><div class="gs_gray">A Åkerblom, L Wallentin, A Larsson, A Siegbahn, RC Becker, A Budaj, ...</div><div class="gs_gray">Clinical chemistry 59 (9), 1369-1375<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7837571521582458966" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: analysis from the&nbsp;…</a><div class="gs_gray">YJ Shimada, S Bansilal, SD Wiviott, RC Becker, RA Harrington, ...</div><div class="gs_gray">American heart journal 177, 1-8<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3820646517126256532" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:_B80troHkn4C" class="gsc_a_at">Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis</a><div class="gs_gray">KF Alsharif, MR Thomas, HM Judge, H Khan, LR Prince, I Sabroe, ...</div><div class="gs_gray">Vascular pharmacology 71, 201-207<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18352743201381417017" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:TlpoogIpr_IC" class="gsc_a_at">Inhibitory mechanisms of very low–dose rivaroxaban in non–ST-elevation myocardial infarction</a><div class="gs_gray">O Borst, P Münzer, N Alnaggar, S Geue, R Tegtmeyer, D Rath, M Droppa, ...</div><div class="gs_gray">Blood advances 2 (6), 715-730<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1903015454334720118" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WZBGuue-350C" class="gsc_a_at">Cost-effectiveness of long-term ticagrelor in patients with prior myocardial infarction: results from the PEGASUS-TIMI 54 trial</a><div class="gs_gray">EA Magnuson, H Li, K Wang, K Vilain, A Shafiq, MP Bonaca, DL Bhatt, ...</div><div class="gs_gray">Journal of the American College of Cardiology 70 (5), 527-538<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1543234997772396713" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LI9QrySNdTsC" class="gsc_a_at">The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA)—a multicentre parallel-group randomised trial to compare early computerised tomography&nbsp;…</a><div class="gs_gray">AJ Gray, C Roobottom, JE Smith, S Goodacre, K Oatey, R O’brien, ...</div><div class="gs_gray">Trials 17 (1), 1-13<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17206054555991087220" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:5awf1xo2G04C" class="gsc_a_at">NLRC4 inflammasome is an important regulator of interleukin-18 levels in patients with acute coronary syndromes: genome-wide association study in the PLATelet inhibition and&nbsp;…</a><div class="gs_gray">Å Johansson, N Eriksson, RC Becker, RF Storey, A Himmelmann, ...</div><div class="gs_gray">Circulation: Cardiovascular Genetics 8 (3), 498-506<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12315329127829570026" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study</a><div class="gs_gray">A Åkerblom, N Eriksson, L Wallentin, A Siegbahn, BJ Barratt, RC Becker, ...</div><div class="gs_gray">American heart journal 168 (1), 96-102. e2<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5637249425363392145" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Ticagrelor: from concept to clinical evaluation</a><div class="gs_gray">JA Shand, IBA Menown, RF Storey</div><div class="gs_gray">Biomarkers in medicine 5 (1), 53-62<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2074428427297980084" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Evolving pattern of platelet P2Y<sub>12</sub> inhibition in patients with acute coronary syndromes</a><div class="gs_gray">RR Joshi, R Hossain, AC Morton, R Ecob, HM Judge, C Wales, JV Walker, ...</div><div class="gs_gray">Platelets 25 (6), 416-422<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7030615197188631869" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)</a><div class="gs_gray">KW Mahaffey, Z Huang, L Wallentin, RF Storey, LK Jennings, P Tricoci, ...</div><div class="gs_gray">The American journal of cardiology 113 (6), 936-944<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14324774321185235970" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:aEW5N-EHWIMC" class="gsc_a_at">Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54</a><div class="gs_gray">RHM Furtado, JC Nicolau, G Magnani, K Im, DL Bhatt, RF Storey, PG Steg, ...</div><div class="gs_gray">European heart journal 41 (17), 1625-1632<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8798891871871510622" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:pYKElYtJMmwC" class="gsc_a_at">Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction</a><div class="gs_gray">B Zwart, M Yazdani, KW Ow, JD Richardson, J Iqbal, JP Gunn, RF Storey</div><div class="gs_gray">Platelets 31 (2), 174-178<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14387592760510141047" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">Pharmacodynamic effects of a 6-hour regimen of enoxaparin in patients undergoing primary percutaneous coronary intervention (PENNY PCI Study)</a><div class="gs_gray">W Sumaya, WAE Parker, R Fretwell, IR Hall, DS Barmby, JD Richardson, ...</div><div class="gs_gray">Thrombosis and haemostasis 118 (07), 1250-1256<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4567785111495290102" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status</a><div class="gs_gray">MR Thomas, DJ Angiolillo, MP Bonaca, RA Ajjan, HM Judge, F Rollini, ...</div><div class="gs_gray">Thrombosis and haemostasis 117 (05), 940-947<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7765764485589730266" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:HIFyuExEbWQC" class="gsc_a_at">Ticagrelor: Effects Beyond the P2Y12 Receptor.</a><div class="gs_gray">W Sumaya, RF Storey</div><div class="gs_gray">Interventional cardiology clinics 6 (1), 49-55<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2115599901511599264" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:olpn-zPbct0C" class="gsc_a_at">Dyspnea related to reversibly-binding P2Y12 inhibitors: a review of the pathophysiology, clinical presentation and diagnostics</a><div class="gs_gray">M Unverdorben, G Parodi, M Pistolesi, RF Storey</div><div class="gs_gray">International journal of cardiology 202, 167-173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9948539026732963403" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy</a><div class="gs_gray">M Janzon, S James, CP Cannon, RF Storey, C Mellström, JC Nicolau, ...</div><div class="gs_gray">Heart 101 (2), 119-125<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6996872367160555418" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:KI9T_ytC6pkC" class="gsc_a_at">Bax JJ</a><div class="gs_gray">AJ Camm, GY Lip, R De Caterina, I Savelieva, D Atar, SH Hohnloser, ...</div><div class="gs_gray">Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C&nbsp;…<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16060979772372890931" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:L1USKYWJimsC" class="gsc_a_at">Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute&nbsp;…</a><div class="gs_gray">F Franchi, SK James, T Ghukasyan Lakic, AJ Budaj, JH Cornel, HA Katus, ...</div><div class="gs_gray">Journal of the American Heart Association 8 (6), e011139<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10014030553915047527,15405856513839308185" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">Frequency, predictors, and impact of combined antiplatelet therapy on venous thromboembolism in patients with symptomatic atherosclerosis</a><div class="gs_gray">I Cavallari, DA Morrow, MA Creager, J Olin, DL Bhatt, PG Steg, RF Storey, ...</div><div class="gs_gray">Circulation 137 (7), 684-692<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9125732592321734274" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:DUooU5lO8OsC" class="gsc_a_at">Growth differentiation factor 15 at 1 month after an acute coronary syndrome is associated with increased risk of major bleeding</a><div class="gs_gray">D Lindholm, E Hagström, SK James, RC Becker, CP Cannon, ...</div><div class="gs_gray">Journal of the American Heart Association 6 (4), e005580<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=916316018879037485" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Impact of aspirin dosing on the effects of P2Y 12 inhibition in patients with acute coronary syndromes</a><div class="gs_gray">MR Thomas, RF Storey</div><div class="gs_gray">Journal of cardiovascular translational research 7 (1), 19-28<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10097954370617318674" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Optimal management of antiplatelet therapy and proton pump inhibition following percutaneous coronary intervention</a><div class="gs_gray">MR Thomas, RF Storey</div><div class="gs_gray">Current treatment options in cardiovascular medicine 14 (1), 24-38<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11726967965029813028" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Bleeding risk with AZD6140, a reversible P2Y<sub>12</sub> receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial</a><div class="gs_gray">S Husted, RA Harrington, CP Cannon, RF Storey, P Mitchell, ...</div><div class="gs_gray">International journal of clinical practice 63 (4), 667-670<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9189222257144558890" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Clopidogrel resistance.</a><div class="gs_gray">S Heptinstall, JR Glenn, JA May, RF Storey, RG Wilcox</div><div class="gs_gray">Catheterization and cardiovascular interventions: official journal of the&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15981520627334782549" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-nhnvRiOwuoC" class="gsc_a_at">Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS</a><div class="gs_gray">M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ...</div><div class="gs_gray">Revista espanola de cardiologia (English ed.) 71 (1), 42<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8738954892712782521,13741091918979470584" class="gsc_a_ac gs_ibl">17</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="-plVGtcAAAAJ:-nhnvRiOwuoC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ojlX30-wUrgC" class="gsc_a_at">EHRA CONSENSUS DOCUMENT</a><div class="gs_gray">GYH Lip, JP Collet, R de Caterina, L Fauchier, DA Lane, TB Larsen, ...</div><div class="gs_gray">Europace 19, 1757-1758<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2892383510989348572" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Vr2j17o0sqMC" class="gsc_a_at">CXC ligand 16 is an independent predictor of cardiovascular death and morbidity in acute coronary syndromes</a><div class="gs_gray">T Andersen, T Ueland, T Ghukasyan Lakic, A Åkerblom, M Bertilsson, ...</div><div class="gs_gray">Arteriosclerosis, thrombosis, and vascular biology 39 (11), 2402-2410<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4745103128749912358" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PyEswDtIyv0C" class="gsc_a_at">Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54</a><div class="gs_gray">M Dellborg, MP Bonaca, RF Storey, PG Steg, KA Im, M Cohen, DL Bhatt, ...</div><div class="gs_gray">European Heart Journal-Cardiovascular Pharmacotherapy 5 (4), 200-206<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=292899814404091052,10141854226890077095" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SxCCDk4iOpsC" class="gsc_a_at">Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome</a><div class="gs_gray">WAE Parker, RC Orme, J Hanson, HM Stokes, CM Bridge, PA Shaw, ...</div><div class="gs_gray">Platelets 30 (2), 148-157<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7532897479870569988" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:C33y2ycGS3YC" class="gsc_a_at">Prolonged prothrombotic effects of antecedent hypoglycemia in individuals with type 2 diabetes</a><div class="gs_gray">E Chow, A Iqbal, E Walkinshaw, F Phoenix, IA Macdonald, RF Storey, ...</div><div class="gs_gray">Diabetes Care 41 (12), 2625-2633<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10231648167375156793" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Platelet-related biomarkers and their response to inhibition with aspirin and p2y 12-receptor antagonists in patients with acute coronary syndrome</a><div class="gs_gray">A Lowenstern, RF Storey, M Neely, JL Sun, DJ Angiolillo, CP Cannon, ...</div><div class="gs_gray">Journal of thrombosis and thrombolysis 44 (2), 145-153<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2010451222252510136" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors</a><div class="gs_gray">MR Thomas, RF Storey</div><div class="gs_gray">Vascular pharmacology 84, 25-27<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3846195962237063920" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:8AbLer7MMksC" class="gsc_a_at">New P2Y12 inhibitors</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Heart 97 (15), 1262-1267<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14349761501272782067" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:vVJNg6_NJEsC" class="gsc_a_at">Impaired fibrinolysis predicts adverse outcome in acute coronary syndrome patients with diabetes: a PLATO sub-study</a><div class="gs_gray">W Sumaya, L Wallentin, SK James, A Siegbahn, K Gabrysch, ...</div><div class="gs_gray">Thrombosis and haemostasis 120 (03), 412-422<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14743856891013309639" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BJrgspguQaEC" class="gsc_a_at">Dual antiplatelet or dual antithrombotic therapy for secondary prevention in high-risk patients with stable coronary artery disease?</a><div class="gs_gray">W Sumaya, T Geisler, SD Kristensen, RF Storey</div><div class="gs_gray">Thrombosis and haemostasis 119 (10), 1583-1589<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11854478397111498908" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Wq2b2clWBLsC" class="gsc_a_at">morphine and ticagrelor interaction in primary percutaneous coronary intervention in st-segment elevation myocardial infarction: ATLANTIC-Morphine</a><div class="gs_gray">F Lapostolle, AW van’t Hof, CW Hamm, O Stibbe, P Ecollan, JP Collet, ...</div><div class="gs_gray">American Journal of Cardiovascular Drugs 19 (2), 173-183<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3354998017675946615" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial</a><div class="gs_gray">E Fabris, A van’t Hof, CW Hamm, F Lapostolle, JF Lassen, SG Goodman, ...</div><div class="gs_gray">European Heart Journal: Acute Cardiovascular Care 8 (3), 208-217<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13435691424847423616" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Population pharmacokinetics of ticagrelor in patients with acute coronary syndromes</a><div class="gs_gray">J Li, W Tang, RF Storey, S Husted, R Teng</div><div class="gs_gray">International journal of clinical pharmacology and therapeutics 54 (9), 666<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18226661680472364941" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Genetics of response to antiplatelet therapy</a><div class="gs_gray">MR Thomas, RF Storey</div><div class="gs_gray">Progress in molecular biology and translational science 124, 123-153<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13195972862943165994" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">First clinical study of the novel platelet ADP receptor (P-2 gamma) antagonist AR-C69931MX, assessing safety, tolerability and activity in patients with acute coronary syndromes</a><div class="gs_gray">RF Storey, KG Oldroyd, RG Wilcox</div><div class="gs_gray">Circulation 100 (18), 710-710<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8982316828917921819" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Ej9njvOgR2oC" class="gsc_a_at">Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European&nbsp;…</a><div class="gs_gray">DA Gorog, S Price, D Sibbing, A Baumbach, D Capodanno, B Gigante, ...</div><div class="gs_gray">European Heart Journal-Cardiovascular Pharmacotherapy 7 (2), 125-140<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12079569222551423845" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sbeIDTyQOFgC" class="gsc_a_at">Post-discharge bleeding and mortality following acute coronary syndromes with or without PCI</a><div class="gs_gray">G Marquis-Gravel, F Dalgaard, AD Jones, Y Lokhnygina, SK James, ...</div><div class="gs_gray">Journal of the American College of Cardiology 76 (2), 162-171<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13404949873035180630" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ijdKiLOsEJMC" class="gsc_a_at">Design and rationale of the COMPLETE trial: a randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat&nbsp;…</a><div class="gs_gray">SR Mehta, DA Wood, B Meeks, RF Storey, R Mehran, KR Bainey, ...</div><div class="gs_gray">American heart journal 215, 157-166<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7715428551931479433" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:rmuvC79q63oC" class="gsc_a_at">Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at&nbsp;…</a><div class="gs_gray">E Giannitsis, L Wallentin, SK James, M Bertilsson, A Siegbahn, RF Storey, ...</div><div class="gs_gray">European Heart Journal: Acute Cardiovascular Care 6 (6), 500-510<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=174262021082928859" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Cangrelor for the management and prevention of arterial thrombosis</a><div class="gs_gray">RF Storey, A Sinha</div><div class="gs_gray">Expert review of cardiovascular therapy 14 (9), 991-999<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2223613237439726831" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Studies of the interaction of ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes</a><div class="gs_gray">A Björquist, CA Di Buduo, EA Femia, RF Storey, RC Becker, A Balduini, ...</div><div class="gs_gray">Thrombosis and haemostasis 116 (12), 1079-1088<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14903194185892072603" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:uWiczbcajpAC" class="gsc_a_at">Exploring Mechanisms of Graft Occlusion: Toward Improved Outcomes in Coronary Artery Bypass Graft Surgery</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Journal of the American College of Cardiology 57 (9), 1078-1080<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12612891016731027932" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:5ugPr518TE4C" class="gsc_a_at">Clinical experience with antithrombotic drugs acting on purine receptor pathways</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Drug development research 52 (1‐2), 202-212<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13705300476527842087" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:z6xuaG2dYH0C" class="gsc_a_at">Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial</a><div class="gs_gray">T Ueland, A Åkerblom, T Ghukasyan, AE Michelsen, RC Becker, ...</div><div class="gs_gray">Arteriosclerosis, thrombosis, and vascular biology 39 (2), 294-302<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10879299278300469094" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non–ST‐segment elevation acute coronary syndrome in the PLATO trial</a><div class="gs_gray">CV Pollack Jr, F Davoudi, DB Diercks, RC Becker, SK James, ST Lim, ...</div><div class="gs_gray">Clinical cardiology 40 (6), 390-398<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=989022751419676127" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">The future of P2Y<sub>12</sub> receptor antagonists</a><div class="gs_gray">MR Thomas, RF Storey</div><div class="gs_gray">Platelets 26 (5), 392-398<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1777163251173784604" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:AZju0d2GQJ0C" class="gsc_a_at">Antithrombotics: from aspirin to DOACs in coronary artery disease and atrial fibrillation (Part 3/5)</a><div class="gs_gray">FWA Verheugt, JM Ten Berg, RF Storey, T Cuisset, CB Granger</div><div class="gs_gray">Journal of the American College of Cardiology 74 (5), 699-711<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=316513251719407470" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:YB4bud6kWLwC" class="gsc_a_at">Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54</a><div class="gs_gray">M Dellborg, MP Bonaca, RF Storey, PG Steg, KA Im, M Cohen, DL Bhatt, ...</div><div class="gs_gray">European Heart Journal 38 (S1), 794-795<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4791513741533558642" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:7H_MAutzIkAC" class="gsc_a_at">Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial</a><div class="gs_gray">E Fabris, A Van't Hof, CW Hamm, F Lapostolle, JF Lassen, SG Goodman, ...</div><div class="gs_gray">EuroIntervention 13 (1), 69-77<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14942519501944362312" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">Ticagrelor plasma levels but not clinical outcomes are associated with transporter and metabolism enzyme genetic polymorphisms</a><div class="gs_gray">C Varenhorst, N Eriksson, Å Johansson, B Barratt, A Åkerblom, ...</div><div class="gs_gray">Journal of the American College of Cardiology 63 (12S), A25-A25<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6573236475597744731" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Can we improve the efficacy of low-dose aspirin?</a><div class="gs_gray">EL Grove, RF Storey, SD Kristensen</div><div class="gs_gray">Thrombosis and haemostasis 112 (12), 1077-1078<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2651818983441931685" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">Linee guida ESC per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il&nbsp;…</a><div class="gs_gray">CW Hamm, JP Bassand, S Agewall, J Bax, E Boersma, H Bueno, P Caso, ...</div><div class="gs_gray">Giornale italiano di cardiologia 13 (3), 171-228<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7261238868871711725" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:wBLCggQE-ToC" class="gsc_a_at">ESC/EAS Guidelines for the management of dyslipidaemias</a><div class="gs_gray">EAS de la Sociedad Europea de Aterosclerosis, Ž Reiner, AL Catapano, ...</div><div class="gs_gray">Revista Española de Cardiología (English Edition) 64 (12), 1168<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15481302133952539967" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:naSTrk-c4S8C" class="gsc_a_at">Wytyczne ESC/EAS dotyczące postępowania w dyslipidemiach</a><div class="gs_gray">SN i Rehabilitacji</div><div class="gs_gray">Kardiologia Polska 69 (supl IV), 143-200<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10255289879549829460" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">The right oral antithrombotics in acute coronary syndromes.</a><div class="gs_gray">EL Grove, RF Storey</div><div class="gs_gray">Lancet (London, England) 374 (9706), 1947-1948<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2272398196368778034" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:6ZzL7HXColQC" class="gsc_a_at">Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and&nbsp;…</a><div class="gs_gray">WAE Parker, C Schulte, T Barwari, F Phoenix, SM Pearson, M Mayr, ...</div><div class="gs_gray">Cardiovascular diabetology 19 (1), 1-13<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8934386648904468887" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:RfUwGJFMQ-0C" class="gsc_a_at">Clinical application of high-sensitivity troponin testing in the atherosclerotic cardiovascular disease framework of the current cholesterol guidelines</a><div class="gs_gray">NA Marston, MP Bonaca, P Jarolim, EL Goodrich, DL Bhatt, PG Steg, ...</div><div class="gs_gray">JAMA cardiology 5 (11), 1255-1262<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=400209326610741964" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">Association of the coronary artery disease risk gene <i>GUCY1A3</i> with ischaemic events after coronary intervention</a><div class="gs_gray">T Kessler, B Wolf, N Eriksson, D Kofink, BK Mahmoodi, H Rai, V Tragante, ...</div><div class="gs_gray">Cardiovascular research 115 (10), 1512-1518<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=793170977408044403" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Reduction in subtypes and sizes of myocardial infarction with ticagrelor in PEGASUS–TIMI 54</a><div class="gs_gray">MP Bonaca, SD Wiviott, DA Morrow, PG Steg, C Hamm, DL Bhatt, ...</div><div class="gs_gray">Journal of the American Heart Association 7 (22), e009260<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=292820009646120101" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Design and rationale of TROCADERO: a trial of caffeine to alleviate dyspnea related to ticagrelor</a><div class="gs_gray">D Lindholm, RF Storey, C Christersson, S Halvorsen, EL Grove, OÖ Braun, ...</div><div class="gs_gray">American heart journal 170 (3), 465-470<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5186999159657902200" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary&nbsp;…</a><div class="gs_gray">L Wallentin, RC Becker, CP Cannon, C Held, A Himmelmann, S Husted, ...</div><div class="gs_gray">International journal of cardiology 170 (3), e59-e62<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6691732979937525475" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Mojj43d5GZwC" class="gsc_a_at">Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials</a><div class="gs_gray">SK James, KS Pieper, CP Cannon, RF Storey, RC Becker, PG Steg, ...</div><div class="gs_gray">Stroke 44 (5), 1477-1479<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17419617512577526925" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:W5xh706n7nkC" class="gsc_a_at">Hirudin anticoagulation allows more rapid determination of P2Y12 inhibition by the VerifyNow P2Y12 assay</a><div class="gs_gray">W Sumaya, RL Daly, S Mehra, AJ Dhutia, KE Howgego, R Ecob, ...</div><div class="gs_gray">Thrombosis and haemostasis 109 (03), 550-555<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7693928083172047313" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:J-pR_7NvFogC" class="gsc_a_at">AZD6140 yields greater inhibition of platelet aggregation than clopidogrel in patients with acute coronary syndromes without previous clopidogrel treatment</a><div class="gs_gray">RF Storey, S Husted, RA Harrington, S Heptinstall, RG Wilcox, PA Gurbel, ...</div><div class="gs_gray">JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 204A-204A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10333498061634824225" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:0sTkTiv_uMkC" class="gsc_a_at">Novel approaches to P2Y<sub>12</sub> inhibition and aspirin dosing</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">Platelets 32 (1), 7-14<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17976248110422752944" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:idthP5jqfYAC" class="gsc_a_at">Gut microbiota‐dependent trimethylamine N‐oxide and cardiovascular outcomes in patients with prior myocardial infarction: a nested case control study from the PEGASUS‐TIMI 54 trial</a><div class="gs_gray">B Gencer, XS Li, Y Gurmu, MP Bonaca, DA Morrow, M Cohen, DL Bhatt, ...</div><div class="gs_gray">Journal of the American Heart Association 9 (10), e015331<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9402384832487709424" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:N4u4nq0IxgcC" class="gsc_a_at">Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial</a><div class="gs_gray">A Åkerblom, D Wojdyla, PG Steg, L Wallentin, SK James, A Budaj, ...</div><div class="gs_gray">Journal of thrombosis and thrombolysis 48 (4), 563-569<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6251860054666619760" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BzfGm06jWhQC" class="gsc_a_at">Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study</a><div class="gs_gray">WA Parker, DL Bhatt, J Prats, JRS Day, PG Steg, GW Stone, CW Hamm, ...</div><div class="gs_gray">Thrombosis and haemostasis 117 (06), 1093-1100<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12616052120435829869" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex</a><div class="gs_gray">N Kholaif, Y Zheng, P Jagasia, A Himmelmann, SK James, PG Steg, ...</div><div class="gs_gray">The American journal of medicine 128 (8), 914. e11-914. e19<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8728556953515592162" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ye4kPcJQO24C" class="gsc_a_at">Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudy</a><div class="gs_gray">PW Armstrong, CM Westerhout, Y Fu, RA Harrington, RF Storey, H Katus, ...</div><div class="gs_gray">The American journal of medicine 126 (8), 723-729. e1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1304900161793488521" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sJPMR1oEGYQC" class="gsc_a_at">Israrcı ST-Segment Yükselmesi Belirtileri Göstermeyen Hastalarda Akut Koroner Sendromların (AKS) tedavi Kılavuzları</a><div class="gs_gray">CW Hamm, JP Bassand, S Agewall, J Bax, E Boersma, H Bueno, P Caso, ...</div><div class="gs_gray">TurkKardiyolDern Arş, 73-128<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5021576737472673931" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Cangrelor inhibits the binding of clopidogrel and prasugrel active metabolites to the P2Y12 receptor</a><div class="gs_gray">R Buckland, HM Judge, A Sugidachi, JA Jakubowski, RF Storey</div><div class="gs_gray">EUROPEAN HEART JOURNAL 30, 193-193<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1503525045635623128" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Electrocardiogram interpretation as a basis for thrombolysis</a><div class="gs_gray">RF Storey, JM Rowley</div><div class="gs_gray">Journal of the Royal College of Physicians of London 31 (5), 536<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10466435576085623493" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:VRfTbSk87rEC" class="gsc_a_at">Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel</a><div class="gs_gray">MR Thomas, SK James, RC Becker, A Himmelmann, HA Katus, ...</div><div class="gs_gray">European Heart Journal Acute Cardiovascular Care 10 (2), 153-163<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5025367288439865629" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:q0uBw5dMOAkC" class="gsc_a_at">Circulating MicroRNA levels indicate platelet and leukocyte activation in endotoxemia despite platelet P2Y12 inhibition</a><div class="gs_gray">A Braza-Boïls, T Barwari, C Gutmann, MR Thomas, HM Judge, A Joshi, ...</div><div class="gs_gray">International journal of molecular sciences 21 (8), 2897<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6991539532479617393" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:qE4H1tSSYIIC" class="gsc_a_at">Pharmacokinetic–pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients</a><div class="gs_gray">M Åstrand, C Amilon, D Röshammar, A Himmelmann, DJ Angiolillo, ...</div><div class="gs_gray">British journal of clinical pharmacology 85 (2), 413-421<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13114848687176759625" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Antiplatelet therapy, platelet function testing, and bleeding complications in cardiac surgery patients</a><div class="gs_gray">EC Hansson, A Jeppsson</div><div class="gs_gray">Seminars in thrombosis and hemostasis 43 (07), 699-705<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16304569236495705004" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tYavs44e6CUC" class="gsc_a_at">Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarction</a><div class="gs_gray">D Röshammar, M Bergstrand, T Andersson, RF Storey, B Hamrén</div><div class="gs_gray">International journal of clinical pharmacology and therapeutics 55 (5), 416<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10317308233298426846" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Impact of morphine administration on ticagrelor-induced platelet inhibition in ST-elevation myocardial infarction patients treated by primary PCI: results from the PRIVATE&nbsp;…</a><div class="gs_gray">J Silvain, R Storey, G Cayla, JB Esteve, JG Dillinger, E Vicaut, JP Collet, ...</div><div class="gs_gray">Journal of the American College of Cardiology 65 (10S), A15-A15<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17182446312576944534" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:evX43VCCuoAC" class="gsc_a_at">Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—results from the PLATelet inhibition and patient&nbsp;…</a><div class="gs_gray">A Åkerblom, L Wallentin, A Siegbahn, RC Becker, A Budaj, J Horrow, ...</div><div class="gs_gray">American heart journal 164 (5), 728-734<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10239232813232877406" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Рекомендации Европейского общества кардиологов и Европейского общества атеросклероза по лечению дислипидемий</a><div class="gs_gray">R Zeljko, BG De, G Ian, T Marja-Riitta, W Olov, A Stefan, A Eduardo, ...</div><div class="gs_gray">Рациональная фармакотерапия в кардиологии 8 (1s)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11686979096645198200" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hHIA4WEVY-EC" class="gsc_a_at">New antithrombotic drugs in acute coronary syndrome</a><div class="gs_gray">B Zwart, WAE Parker, RF Storey</div><div class="gs_gray">Journal of Clinical Medicine 9 (7), 2059<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16571705352786869619" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:XDrR66g3YHsC" class="gsc_a_at">Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized&nbsp;…</a><div class="gs_gray">M Tomaniak, P Chichareon, D Klimczak-Tomaniak, K Takahashi, ...</div><div class="gs_gray">Clinical research in cardiology 109 (7), 930-943<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7041610834323431666" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:rOcdG6UcVlcC" class="gsc_a_at">Efficacy and safety of glycoprotein IIb/IIIa inhibitors on top of Ticagrelor in STEMI: a subanalysis of the ATLANTIC trial</a><div class="gs_gray">AH Tavenier, RS Hermanides, E Fabris, F Lapostolle, J Silvain, M Jurrien, ...</div><div class="gs_gray">Thrombosis and haemostasis 120 (01), 065-074<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7721344377305588248" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:lYAcb2jw7qUC" class="gsc_a_at">Ticagrelor in patients with heart failure after acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial</a><div class="gs_gray">A Åkerblom, DM Wojdyla, L Wallentin, SK James, F de Souza Brito, ...</div><div class="gs_gray">American heart journal 213, 57-65<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9231081585570706328" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Osteoprotegerin is associated with major bleeding but not with cardiovascular outcomes in patients with acute coronary syndromes: insights from the PLATO (Platelet Inhibition&nbsp;…</a><div class="gs_gray">T Ueland, A Åkerblom, T Ghukasyan, AE Michelsen, P Aukrust, ...</div><div class="gs_gray">Journal of the American Heart Association 7 (2), e007009<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14625859557288592436" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-jrNzM816MMC" class="gsc_a_at">The IL-1RI Co-Receptor TILRR (<i>FREM1</i> Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease</a><div class="gs_gray">SA Smith, AO Samokhin, M Alfaidi, EC Murphy, D Rhodes, ...</div><div class="gs_gray">Basic to Translational Science 2 (4), 398-414<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9673023549136938482" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:7wO8s98CvbsC" class="gsc_a_at">Ticagrelor: agonising over its mechanisms of action</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 128 (23), 2595-2597<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14884629576153619965" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:3lUAU8Oskd0C" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with non-st-elevation acute coronary syndrome: results from the plato trial</a><div class="gs_gray">D Lindholm, C Varenhorst, C Cannon, R Harrington, A Himmelmann, ...</div><div class="gs_gray">Journal of the American College of Cardiology 61 (10S), E1-E1<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1938116132394681482" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Proton pump inhibitor use is likely a marker for, rather than a cause of, a higher risk of cardiovascular events: insights from PLATO</a><div class="gs_gray">SG Goodman, R Clare, KS Pieper, SK James, JC Nicolau, RF Storey, ...</div><div class="gs_gray">Circulation 122 (suppl_21), A12092-A12092<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10023811892246094666" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Ticagrelor does not affect pulmonary function tests compared to clopidogrel in acute coronary syndromes: results of the PLATO pulmonary substudy</a><div class="gs_gray">RF Storey, RC Becker, CP Cannon, F Cools, H Emanuelsson, ...</div><div class="gs_gray">Journal of the American College of Cardiology 55 (10S), A108. E1007-A108. E1007<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2191381927600821962" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PELIpwtuRlgC" class="gsc_a_at">The effect of ticagrelor in stable coronary artery disease patients nonresponsive to clopidogrel: the RESPOND study</a><div class="gs_gray">P Gurbel, K Bliden, M Antonino, K Butler, R Teng, L Rasmussen, AS Syd, ...</div><div class="gs_gray">Circulation 120 (suppl_18), S1173-S1173<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=777225396006393931" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes scheduled for coronary intervention</a><div class="gs_gray">A Siotia, R Buckland, HM Judge, P Sastry, RF Storey</div><div class="gs_gray">Thrombosis and haemostasis 95 (06), 997-1002<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18045445477461161366" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:i_7YvbSbtFEC" class="gsc_a_at">Nonculprit lesion severity and outcome of revascularization in patients with STEMI and multivessel coronary disease</a><div class="gs_gray">T Sheth, N Pinilla-Echeverri, R Moreno, J Wang, DA Wood, RF Storey, ...</div><div class="gs_gray">Journal of the American College of Cardiology 76 (11), 1277-1286<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16943151031569569684" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:8VtEwCQfWZkC" class="gsc_a_at">Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y<sub>12</sub> receptor antagonist</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">Expert opinion on emerging drugs 25 (1), 1-6<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5266086117753042196" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:_tF6a-HnqWAC" class="gsc_a_at">Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?</a><div class="gs_gray">M Tomaniak, RF Storey, PW Serruys</div><div class="gs_gray">EuroIntervention 15 (13), 1125-1129<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1660789264859040391" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:QsKbpXNoaWkC" class="gsc_a_at">Interleukin‐18 in patients with acute coronary syndromes</a><div class="gs_gray">A Åkerblom, SK James, TG Lakic, RC Becker, CP Cannon, PG Steg, ...</div><div class="gs_gray">Clinical cardiology 42 (12), 1202-1209<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14924032543167424865" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BmWJbWwHJAwC" class="gsc_a_at">Combining DAPT with a PPI faces the acid test of real-world use</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">European heart journal 40 (24), 1971-1974<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17507428855436509035" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Dual antiplatelet therapy in the ‘real world’</a><div class="gs_gray">ENC Onwordi, WAE Parker, RF Storey</div><div class="gs_gray">Heart 104 (19), 1555-1556<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11854237993720451173" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BAanoTsO0WEC" class="gsc_a_at">REDUCTION IN ISCHEMIC EVENTS WITH TICAGRELOR IN DIABETIC PATIENTS FROM THE PEGASUS-TIMI 54 TRIAL</a><div class="gs_gray">DL Bhatt, M Bonaca, S Bansilal, M Cohen, RF Storey, K Im, S Murphy, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (13S), 2111-2111<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5451004465844125227" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in patients with prior mi and multivessel coronary disease: insights from the&nbsp;…</a><div class="gs_gray">S Bansilal, M Bonaca, JH Cornel, R Storey, D Bhatt, P Steg, K Im, P Held, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (13S), 2146-2146<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2347787354317264723" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:uLbwQdceFCQC" class="gsc_a_at">TCT-78 efficacy of long-term ticagrelor in stented patients in PEGASUS-TIMI 54</a><div class="gs_gray">MP Bonaca, DL Bhatt, PG Steg, A Budaj, S Bansilal, RF Storey, KA Im, ...</div><div class="gs_gray">Journal of the American College of Cardiology 66 (15S), B36-B36<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14135101613129941677" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:VLnqNzywnoUC" class="gsc_a_at">More transparency for a therapeutic window in platelet P2Y<sub>12</sub> inhibition?</a><div class="gs_gray">RF Storey</div><div class="gs_gray">European heart journal 36 (27), 1714-1717<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18005864609206856139" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Stability of VerifyNow P2Y12 assay results with citrate anticoagulation as compared to hirudin anticoagulation over 20-min period</a><div class="gs_gray">W Sumaya, RR Joshi, HM Judge, R Ecob, AC Morton, RF Storey</div><div class="gs_gray">Platelets 26 (3), 271-273<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7518451509644977964" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:JQOojiI6XY0C" class="gsc_a_at">No misrepresentation of vital status follow-up in PLATO: Predefined analyses guarantee the integrity of the benefits of ticagrelor over clopidogrel in the PLATO trial&nbsp;…</a><div class="gs_gray">L Wallentin, RC Becker, CP Cannon, C Held, A Himmelmann, S Husted, ...</div><div class="gs_gray">International journal of cardiology 176 (1), 300-302<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17183544293203575782" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Outcomes with ticagrelor versus clopidogrel in relation to high sensitivity troponin-T in non-ST-elevation acute coronary syndrome patients managed with early invasive or non&nbsp;…</a><div class="gs_gray">L Wallentin, SK James, E Giannitsis, HA Katus, RC Becker, CP Cannon, ...</div><div class="gs_gray">Circulation 126 (suppl_21), A15929-A15929<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6071986309815816623" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WqliGbK-hY8C" class="gsc_a_at">Increased incidence of dyspnoea associated with ticagrelor did not appear to adversely affect cardiovascular outcomes in the PLATO study</a><div class="gs_gray">RF Storey, RC Becker, RA Harrington, CP Cannon, S Husted, SK James, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 31, 203-203<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15578193765291868038" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:bXQfdp6S9ecC" class="gsc_a_at">Antithrombotic therapy for patients with chronic coronary syndromes</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">Heart 107 (11), 925-933<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9332698906430565945" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Oo1CbQkBAzEC" class="gsc_a_at">Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction</a><div class="gs_gray">G Magnani, D Ardissino, KA Im, A Budaj, RF Storey, PG Steg, DL Bhatt, ...</div><div class="gs_gray">Journal of the American Heart Association 10 (4), e017008<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8647367566419895272" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:oqD4_j7ulsYC" class="gsc_a_at">The long journey of individualizing antiplatelet therapy after acute coronary syndromes</a><div class="gs_gray">RF Storey</div><div class="gs_gray">European Heart Journal 41 (37), 3546-3548<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6324949839824226559" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:R22Rs3tN8aoC" class="gsc_a_at">Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized&nbsp;…</a><div class="gs_gray">M Tomaniak, P Chichareon, K Takahashi, N Kogame, R Modolo, ...</div><div class="gs_gray">European Heart Journal-Cardiovascular Pharmacotherapy 6 (4), 222-230<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14398109930497548901" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:c59VksA5Vz4C" class="gsc_a_at">Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial</a><div class="gs_gray">F Kontny, T Andersen, T Ueland, A Åkerblom, TG Lakic, AE Michelsen, ...</div><div class="gs_gray">European Heart Journal: Acute Cardiovascular Care 9 (4), 313-322<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13125068669666580256" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4Yq6kJLCcecC" class="gsc_a_at">Aspirin and primary prevention in patients with diabetes—a critical evaluation of available randomized trials and meta-analyses</a><div class="gs_gray">K Schrör, SD Kristensen, RF Storey, FWA Verheugt</div><div class="gs_gray">Thrombosis and haemostasis 119 (10), 1573-1582<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16817327631841314479" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:AYInfyleIOsC" class="gsc_a_at">Pre‐hospital administration of ticagrelor in diabetic patients with ST‐elevation myocardial infarction undergoing primary angioplasty: A sub‐analysis of the ATLANTIC trial</a><div class="gs_gray">E Fabris, A Van't Hof, CW Hamm, F Lapostolle, JF Lassen, SG Goodman, ...</div><div class="gs_gray">Catheterization and cardiovascular interventions 93 (7), E369-E377<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12536536954422229158" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Duration of ischemia and treatment effects of pre-versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study</a><div class="gs_gray">A Bagai, SG Goodman, WJ Cantor, E Vicaut, L Bolognese, A Cequier, ...</div><div class="gs_gray">American heart journal 196, 56-64<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=867609857459207978" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Pre-hospital ticagrelor in ST-segment elevation myocardial infarction in the French ATLANTIC population</a><div class="gs_gray">G Cayla, F Lapostolle, P Ecollan, O Stibbe, JF Benezet, P Henry, ...</div><div class="gs_gray">International journal of cardiology 244, 49-53<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1826960061859117543" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:nZcligLrVowC" class="gsc_a_at">Choices for potent platelet inhibition in patients with diabetes mellitus</a><div class="gs_gray">RF Storey, WAE Parker</div><div class="gs_gray">Circulation 134 (11), 793-796<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6057323967132113312" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Relationship between early and late nonsustained ventricular tachycardia and cardiovascular death in patients with acute coronary syndrome in the Platelet Inhibition and&nbsp;…</a><div class="gs_gray">AH Bui, CP Cannon, PG Steg, RF Storey, S Husted, J Guo, KA Im, ...</div><div class="gs_gray">Circulation: Arrhythmia and Electrophysiology 9 (2), e002951<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13006930377400478142" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">Рабочая группа европейского кардиологического общества (ESC). Рекомендации ESC по ведению пациентов с острым коронарным синдромом без стойкого подъема сегмента ST 2015</a><div class="gs_gray">M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...</div><div class="gs_gray">Российский кардиологический журнал 21 (3), 9-63<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1198353110279999337,11981129023025753675" class="gsc_a_ac gs_ibl">5</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="-plVGtcAAAAJ:kz9GbA2Ns4gC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Morphine delays the onset of action of prasugrel in patients with prior history of ST elevation myocardial infarction</a><div class="gs_gray">AC Morton, R Hossain, R Ecob, J Walker, J Gunn, HM Judge, RF Storey</div><div class="gs_gray">Circulation 128 (suppl_22), A11449-A11449<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15487422207734359194" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Cangrelor succeeds, at last, in PCI</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Nature Reviews Cardiology 10 (6), 302-304<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5264220322624500696" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:mel-f30kHHgC" class="gsc_a_at">ESC/EAS Guidelines for the man‑. ESC/EAS Guidelines for the man‑agement of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of&nbsp;…</a><div class="gs_gray">AL Catapano, Z Reiner, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">Atherosclerosis 217 (Suppl 1), S1-44<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14647350617553393925,9683219896482355824" class="gsc_a_ac gs_ibl">5</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="-plVGtcAAAAJ:mel-f30kHHgC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST&nbsp;…</a><div class="gs_gray">CP Cannon, S Husted, RA Harrington, BM Scirica, H Emanuelsson, ...</div><div class="gs_gray">JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 50 (22), 2196-2196<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6776634346750235099" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:N5tVd3kTz84C" class="gsc_a_at">AZD6140 exerts greater inhibition of platelet aggregation than clopidogrel in patients with stable atherosclerotic disease or unstable coronary disease</a><div class="gs_gray">RF Storey, CP Cannon, RA Harrington, PM Sandset, S Heptinstall, ...</div><div class="gs_gray">Circulation 114 (suppl_18), II_698-II_699<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2330214212953215013" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Clinical outcomes with AZD6140, an oral reversible ADP receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes (ACS)</a><div class="gs_gray">CP Cannon, RA Harrington, KW Mahaffey, S Husted, RF Storey, ...</div><div class="gs_gray">JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 199A-200A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15022905471161082992" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:GYcXSSpN504C" class="gsc_a_at">Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention</a><div class="gs_gray">W Sumaya, WAE Parker, HM Judge, IR Hall, RC Orme, Z Adam, ...</div><div class="gs_gray">Platelets 32 (4), 555-559<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=155308215889911367" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:DQNrXyjhriIC" class="gsc_a_at">Clinical application of a novel genetic risk score for ischemic stroke in patients with cardiometabolic disease</a><div class="gs_gray">NA Marston, PN Patel, FK Kamanu, F Nordio, GM Melloni, C Roselli, ...</div><div class="gs_gray">Circulation 143 (5), 470-478<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9864187576994104715" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:gV6rEsy15s0C" class="gsc_a_at">Meta‐analysis of echocardiographic quantification of left ventricular filling pressure</a><div class="gs_gray">R Jones, F Varian, S Alabed, P Morris, A Rothman, AJ Swift, N Lewis, ...</div><div class="gs_gray">ESC heart failure 8 (1), 566-576<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10532514783416270059" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:60iIaj97TE0C" class="gsc_a_at">Opiates and Clopidogrel Efficacy: Lost in Transit?</a><div class="gs_gray">RF Storey, WAE Parker</div><div class="gs_gray">Journal of the American College of Cardiology 75 (3), 301-303<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4974807025323314464" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:qmtmRrLr0tkC" class="gsc_a_at">Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice</a><div class="gs_gray">T Geisler, R Jorbenadze, AF Popov, KL Mueller, D Rath, M Droppa, ...</div><div class="gs_gray">Thrombosis and haemostasis 119 (10), 1590-1605<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13245786299546997744" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Hck25ST_3aIC" class="gsc_a_at">Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes&nbsp;…</a><div class="gs_gray">WAE Parker, N Eriksson, RC Becker, D Voora, A Åkerblom, ...</div><div class="gs_gray">Platelets 30 (5), 579-588<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7546480120274808692" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Exposure‐Response Analyses Supporting Ticagrelor Dosing Recommendation in Patients With Prior Myocardial Infarction</a><div class="gs_gray">D Röshammar, J Nyberg, T Andersson, D Stanski, RF Storey, B Hamrén</div><div class="gs_gray">The Journal of Clinical Pharmacology 57 (5), 573-583<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6601789028683104536" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">Comparison of platelet reactivity in black versus white patients with acute coronary syndromes after treatment with ticagrelor</a><div class="gs_gray">MA Gaglia Jr, MJ Lipinski, T Lhermusier, A Steinvil, S Kiramijyan, ...</div><div class="gs_gray">The American journal of cardiology 119 (8), 1135-1140<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5497249605904983241" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:p__nRnzSRKYC" class="gsc_a_at">Clinical perspectives and pearls from the 2015 ESC NSTE-ACS guidelines</a><div class="gs_gray">M Roffi, B Gencer, RF Storey, F Andreotti, C Patrono</div><div class="gs_gray">Current cardiology reports 18 (5), 1-7<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4108166494001950730" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">The efficacy and safety of ticagrelor in women versus men with a prior myocardial infarction: insights from the PEGASUS-TIMI 54 trial</a><div class="gs_gray">ML O'Donoghue, MP Bonaca, G Magnani, DL Bhatt, M Cohen, PG Steg, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 36, 549-549<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13863803265894170344" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Ticagrelor 60 mg twice-daily provides effective platelet inhibition in patients with prior myocardial infarction: the PEGASUS-TIMI 54 platelet function substudy</a><div class="gs_gray">RF Storey, DJ Angiolillo, MP Bonaca, MR Thomas, DL Bhatt, PG Steg, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 36, 549-549<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7584441993494805219" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">215 Ticagrelor inhibits release of pro-inflammatory cytokines TNF and IL-6 during human endotoxaemia</a><div class="gs_gray">M Thomas, H Judge, D Dockrell, I Sabroe, R Storey</div><div class="gs_gray">Heart 100 (Suppl 3), A117-A118<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2895121789402476597" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Utilisation of novel anti-platelet agents: evidence, guidelines and proven patients’ value</a><div class="gs_gray">L Wallentin, A Himmelmann, RF Storey, PG Steg, RA Harrington, ...</div><div class="gs_gray">Thrombosis and haemostasis 112 (07), 12-14<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11268439572381492181" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:EkHepimYqZsC" class="gsc_a_at">Cytochrome P450 2C19 loss-of-function genetic variants but not paraoxonase-1 activity modulate P2Y12 blockade in response to clopidogrel therapy</a><div class="gs_gray">A Karunakaran, H Judge, A Morton, A Milano, J Arnold, TJ Chico, ...</div><div class="gs_gray">Journal of the American College of Cardiology 58 (20), B45-B45<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13956060896414988180" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Ticagrelor versus Clopidogrel in elderly patients with acute coronary syndromes: a subanalysis from the prospective randomized platelet inhibition and patient outcomes (PLATO&nbsp;…</a><div class="gs_gray">S Husted, S James, RC Becker, J Horrow, H Katus, RF Storey, ...</div><div class="gs_gray">Journal of the American College of Cardiology 57 (14S), E1099-E1099<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15233329393314016509" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for a non-invasive management in the PLATO trial</a><div class="gs_gray">S James, MT Roe, CP Cannon, D Raev, J Horrow, S Husted, F Kontny, ...</div><div class="gs_gray">European Heart Journal 31, 203-203<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=562990284071165968" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function</a><div class="gs_gray">J Stefan, B Andrzej, A Philip</div><div class="gs_gray">Coronary Heart Disease 122, 1056-1067<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17570126616735355642" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:URolC5Kub84C" class="gsc_a_at">Inhibition of platelet aggregation by clopiclogrel is unaffected by the CYP2C19 681G&gt; A polyrnorphism in patients with coronary artery disease</a><div class="gs_gray">SMG Smith, R Buckland, ME Daly, RF Storey</div><div class="gs_gray">JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 49 (9), 375A-375A<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17814240450601509569" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Greater inhibition of platelet aggregation be tolerated?-Evaluation of the bleeding risk of AZD6140 compared with clopidogrel (CLOP) in patients with acute coronary syndromes (ACS)</a><div class="gs_gray">H Emanuelsson, KW Mahaffey, RA Harrington, S Husted, RF Storey, ...</div><div class="gs_gray">JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 212A-212A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11392301614415439715" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">AZD6140 yields additional suppression of platelet aggregation in patients with acute coronary syndromes previously treated with clopidogrel</a><div class="gs_gray">RF Storey, RA Harrington, S Husted, S Heptinstall, RG Wilcox, PA Gurbel, ...</div><div class="gs_gray">JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 204A-204A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1915416274272405726" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:35r97b3x0nAC" class="gsc_a_at">Effect of clopidogrel on procoagulant activity in acute coronary syndromes: evidence for incomplete P2Y12 receptor blockade</a><div class="gs_gray">MW Behan, S Fox, H Sanderson, R Storey</div><div class="gs_gray">Circulation 106 (19), 149-150<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10451963906184403288" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sgsej9ZJWHMC" class="gsc_a_at">Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease</a><div class="gs_gray">WAE Parker, DA Gorog, T Geisler, G Vilahur, D Sibbing, B Rocca, ...</div><div class="gs_gray">European Heart Journal Supplements 22 (Supplement_M), M26-M34<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8893489887144383902" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:g8uWPOAv7ggC" class="gsc_a_at">Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: Effects on platelet function and cellular adenosine uptake</a><div class="gs_gray">KW Ow, WAE Parker, MM Porter, J Hanson, HM Judge, NP Briffa, ...</div><div class="gs_gray">Platelets 31 (7), 945-951<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12679689383623518400" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:rbm3iO8VlycC" class="gsc_a_at">Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis</a><div class="gs_gray">BM Scirica, S Bansilal, F Davoudi, PW Armstrong, RM Clare, PJ Schulte, ...</div><div class="gs_gray">American heart journal 202, 54-60<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9082525099760054270" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes</a><div class="gs_gray">KA Greenhalgh, MW Strachan, S Alzahrani, PD Baxter, KF Standeven, ...</div><div class="gs_gray">Thrombosis and haemostasis 117 (02), 295-302<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5289605233430136249" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Efficacy and safety of ticagrelor as long-term secondary prevention in patients with prior myocardial infarction and peripheral artery disease</a><div class="gs_gray">MP Bonaca, D Bhatt, R Storey, P Steg, M Cohen, J Kuder, KA Im, P Held, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (13S), 2266-2266<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1430776712307797976" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Choosing a perspective on mortality with DAPT</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">European heart journal 37 (4), 386-389<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3415713970781417482" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Near patient anti-platelet response testing over time and gene analysis in patients admitted with acute coronary syndromes</a><div class="gs_gray">V Amoah, RF Storey, AP Worrall, K Goodridge, T Lovatt, A Smallwood, ...</div><div class="gs_gray">Platelets 24 (8), 643-648<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5951125793979829132" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Reduction in pulmonary adverse events and associated sepsis and mortality in acute coronary syndrome patients treated with ticagrelor compared to clopidogrel: a post hoc&nbsp;…</a><div class="gs_gray">RF Storey, P Steg, S James, S Husted, C Cannon, R Becker, J Ycas, ...</div><div class="gs_gray">Journal of the American College of Cardiology 59 (13S), E482-E482<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3333342912202021303" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Contemporary pre-hospital management of ACS patients: results from the EPICOR study</a><div class="gs_gray">PR Sinnaeve, H Bueno, N Danchin, J Sanchez-Covisa, M Licour, ...</div><div class="gs_gray">Congress of the European Society of Cardiology (ESC) 33 (suppl. 1), 314-314<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16951294512751719271" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:q1zXlPLtbUIC" class="gsc_a_at">Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared to clopidogrel: data from the PLATO trial</a><div class="gs_gray">MR Patel, RC Becker, DM Wojdyla, H Emanuelsson, W Hiatt, J Horrow, ...</div><div class="gs_gray">Circulation 124 (suppl_21), A14299-A14299<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13994783911390906624" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tuHXwOkdijsC" class="gsc_a_at">What drives thrombogenesis despite antiplatelet therapy in diabetes mellitus?</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Diabetes and Vascular Disease Research 7 (4), 249-250<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16514304121649367962" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Earlier recovery of platelet function after treatment cessation in ticagrelor-treated patients compared to clopidogrel high responders</a><div class="gs_gray">RF Storey, KP Bliden, SB Patil, A Karunakaran, R Ecob, K Butler, C Wei, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 31, 389-389<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14832188469970026773" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Common sequence variations in the P2Y12 and CYP3A5 genes do not explain variability in the inhibitory effects of clopidogrel therapy</a><div class="gs_gray">SMG Smith, HM Judge, G Peters, M Armstrong, P Fontana, P Gaussem, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 26, 486-486<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12306312110903622567" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:jtI9f0ekYq0C" class="gsc_a_at">In vitro evidence supporting direct platelet P2T receptor antagonism as an alternative strategy to glycoprotein IIb/IIIa receptor antagonism</a><div class="gs_gray">R Storey, S Curry, S Heptinstall</div><div class="gs_gray">Heart 83<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5766748306547917062" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Does occupation of the P-2t, receptor on platelets by ADP lead to a reduced rate of Ca2+ re-uptake following Ca2+ liberation via the P2Y (1) receptor, and is this mediated by a&nbsp;…</a><div class="gs_gray">S Heptinstall, HM Sanderson, JR Glenn, RF Storey, W Losche</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, 355-356<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5422990188036851887" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Tfl4UtY-dJUC" class="gsc_a_at">Antithrombotic therapy in diabetes: which, when, and for how long?</a><div class="gs_gray">RA Ajjan, N Kietsiriroje, L Badimon, G Vilahur, DA Gorog, DJ Angiolillo, ...</div><div class="gs_gray">European heart journal 42 (23), 2235-2259<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8023036345678208868" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:3MwzVuqRcA0C" class="gsc_a_at">Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy</a><div class="gs_gray">TA Nelson, WAE Parker, T Ghukasyan Lakic, J Westerbergh, SK James, ...</div><div class="gs_gray">Platelets, 1-7<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2128536147267994270" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:X4-KO54GjGYC" class="gsc_a_at">Next-generation sequencing of CYP2C19 in stent thrombosis: implications for clopidogrel pharmacogenomics</a><div class="gs_gray">JA Morales-Rosado, K Goel, L Zhang, A Åkerblom, S Baheti, JL Black, ...</div><div class="gs_gray">Cardiovascular Drugs and Therapy 35 (3), 549-559<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=194699822295906372" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Vztgr1qGG8IC" class="gsc_a_at">Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous&nbsp;…</a><div class="gs_gray">Z Hijazi, JH Alexander, Z Li, DM Wojdyla, R Mehran, CB Granger, ...</div><div class="gs_gray">Circulation 143 (12), 1215-1223<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9434422903860726435" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:inmFHauC9wsC" class="gsc_a_at">Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Heart<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16443394743160836346" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Nw_I7GeUguwC" class="gsc_a_at">Platelets and the endothelium: active participants in severe COVID-19 infection</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">Basic to Translational Science 6 (3), 219-221<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3563035566297458052" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:qCpRzq7zkD8C" class="gsc_a_at">A proteomics-based assessment of inflammation signatures in endotoxemia</a><div class="gs_gray">SA Burnap, U Mayr, M Shankar-Hari, F Cuello, MR Thomas, AM Shah, ...</div><div class="gs_gray">Molecular &amp; Cellular Proteomics 20<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12235428511981229589" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tBlTYpvFGQIC" class="gsc_a_at">Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach</a><div class="gs_gray">R Storey, JH Alexander, DM Wojdyla, R Mehran, AN Vora, SG Goodman, ...</div><div class="gs_gray">European Heart Journal 41 (Supplement_2), ehaa946. 1450<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4114423472544737576" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:oursBaop5wYC" class="gsc_a_at">Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the&nbsp;…</a><div class="gs_gray">M Ono, M Tomaniak, W Koenig, R Khamis, R de Silva, P Chichareon, ...</div><div class="gs_gray">European Heart Journal-Cardiovascular Pharmacotherapy<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13910122629706323653" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:uAPFzskPt0AC" class="gsc_a_at">Antithrombotic Therapy after Percutaneous Coronary Intervention of Bifurcation Lesions.</a><div class="gs_gray">M Zimarino, DJ Angiolillo, G Dangas, D Capodanno, E Barbato, JY Hahn, ...</div><div class="gs_gray">Eurointervention: Journal of Europcr in Collaboration with the Working Group&nbsp;…<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4743750363314770692" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:QaSi33NTfwYC" class="gsc_a_at">The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing&nbsp;…</a><div class="gs_gray">M Ono, P Chichareon, M Tomaniak, H Kawashima, K Takahashi, ...</div><div class="gs_gray">Clinical research in cardiology 109 (9), 1125-1139<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1313447515950690683" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:M_lZXyI38BkC" class="gsc_a_at">Complete versus culprit-lesion-only revascularization for ST-segment elevation myocardial infarction: a collaborative meta-analysis of randomized trials</a><div class="gs_gray">KR Bainey, T Engstroem, P Smits, A Gershlick, SK James, R Storey, ...</div><div class="gs_gray">Journal of the American College of Cardiology 75 (11_Supplement_1), 15-15<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4937668638938056963" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ifOnle78iJkC" class="gsc_a_at">Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 chronic coronary&nbsp;…</a><div class="gs_gray">RF Storey, M Valgimigli, T Cuisset, D Capodanno, W Wijns, J Knuuti</div><div class="gs_gray">European heart journal 41 (3), 483-484<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8148727050789067617" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:rbGdIwl2e6cC" class="gsc_a_at">Guía ESC 2019 sobre el diagnóstico y tratamiento de los síndromes coronarios crónicos</a><div class="gs_gray">J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ...</div><div class="gs_gray">Revista española de cardiología 73 (6), 495-495<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=379241516497956784" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PlWzFYVEG4EC" class="gsc_a_at">ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial</a><div class="gs_gray">T Ueland, A Åkerblom, T Ghukasyan, AE Michelsen, RC Becker, ...</div><div class="gs_gray">Atherosclerosis 293, 35-41<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11774874818076076661" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">Long-Term Secondary Prevention With Ticagrelor for Prior Myocardial Infarction in Patients With No Coronary Stenting: A Sub-Analysis From PEGASUS TIMI 54</a><div class="gs_gray">RH Furtado, DL Bhatt, PG Steg, M Cohen, RF Storey, KW Im, MS Sabatine, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A14161-A14161<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17122198448871684807" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:T_ojBgVMvoEC" class="gsc_a_at">High-Sensitivity Cardiac Troponin at Any Detectable Concentration Identifies Higher Risk of Major Cardiovascular Events in Patients With Stable Ischemic Heart Disease</a><div class="gs_gray">NA Marston, MP Bonaca, P Jarolim, DL Bhatt, PG Steg, M Cohen, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A13389-A13389<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14233720243244783074" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Consistent benefit of ticagrelor both early and late in patients with prior MI in PEGASUS-TIMI 54</a><div class="gs_gray">MP Bonaca, RF Storey, P Theroux, PG Steg, DL Bhatt, KA Im, G Magnani, ...</div><div class="gs_gray">Circulation 132 (suppl_3), A19642-A19642<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4238961235256507447" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:0izLItjtcgwC" class="gsc_a_at">Activated leukocyte cell adhesion molecule (alcam) and outcomes in acute coronary syndromes: a plato biomarker substudy</a><div class="gs_gray">L Wallentin, AE Michelsen, P Aukrust, R Becker, M Bertilsson, A Budaj, ...</div><div class="gs_gray">Journal of the American College of Cardiology 65 (10S), A231-A231<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18245013151880154476" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Ticagrelor inhibits changes in fibrin clot structure induced by bacterial endotoxemia</a><div class="gs_gray">MR Thomas, RA Ajjan, F Phoenix, SN Outteridge, DH Dockrell, I Sabroe, ...</div><div class="gs_gray">Journal of the American College of Cardiology 65 (10S), A12-A12<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9642098906172955252" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Response to Letter Regarding Article,“Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes: An Analysis From the Prospective&nbsp;…</a><div class="gs_gray">PG Steg, RA Harrington, H Emanuelsson, HA Katus, KW Mahaffey, ...</div><div class="gs_gray">Circulation 129 (19), e494-e495<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4036778116885732702" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:F9fV5C73w3QC" class="gsc_a_at">Modulation of complement C3 levels and fibrin clot structure: the role of aspirin dose</a><div class="gs_gray">KA Hess, Z Kurdee, N Oxley, F Phoenix, N Marx, R King, RF Storey, ...</div><div class="gs_gray">European Heart Journal 34 (suppl_1)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5467457778178407333,12662764140355103698" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">The efficacy and safety of ticagrelor as compared to clopidogrel, with and without a glycoprotein IIB/IIIA inhibitor in patients with acute coronary syndromes undergoing&nbsp;…</a><div class="gs_gray">S Bansilal, S Wiviott, R Becker, R Harrington, A Himmelmann, B Neely, ...</div><div class="gs_gray">Journal of the American College of Cardiology 61 (10S), E1858-E1858<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10457028415129676967" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:0N-VGjzr574C" class="gsc_a_at">Consistent benefit of ticagrelor compared to clopidogrel in acute coronary syndrome patients regardless of baseline inflammatory markers</a><div class="gs_gray">RF Storey, S James, N Åsenblad, A Siegbahn, H Emanuelsson, H Katus, ...</div><div class="gs_gray">Journal of the American College of Cardiology 59 (13S), E505-E505<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11261192230155855685" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">Greater efficacy of ticagrelor compared to clopidogrel in acute coronary syndrome is not driven by outcomes in poor metabolizers of clopidogrel</a><div class="gs_gray">L Wallentin, S James, R Storey, B Barratt, J Horrow, S Husted, H Katus, ...</div><div class="gs_gray">Journal of the American College of Cardiology 59 (13S), E500-E500<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4063667173115077857" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">TICAGRELOR VERSUS CLOPIDOGREL IN WOMEN WITH ACUTE CORONARY SYNDROMES–A SUBSTUDY FROM THE PROSPECTIVE RANDOMIZED PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL</a><div class="gs_gray">S Husted, S James, R Becker, J Horrow, H Katus, R Storey, C Cannon, ...</div><div class="gs_gray">Journal of the American College of Cardiology 59 (13S), E507-E507<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1681146663721720077" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:wGzT3bKASkAC" class="gsc_a_at">Third universal definition of myocardial infarction</a><div class="gs_gray">B Subcommittee, ECG Subcommitteem, J ESC, K Thygesen, JS Alpert, ...</div><div class="gs_gray">J Am Coll Cardiol 60, 1581-1598<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3554637658637993964" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Current regional differences in the use of antiplatelet drugs for the treatment of acute coronary syndromes: results from the EPICOR study</a><div class="gs_gray">H Bueno, RF Storey, N Danchin, J Sanchez-Covisa, O Sazova, M Licour, ...</div><div class="gs_gray">Congress of the European Society of Cardiology (ESC) 33 (suppl. 1), 311-311<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9079670370184375790" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:M7yex6snE4oC" class="gsc_a_at">The Incidence of Arrhythmias and Clinical Arrhythmic Events in Patients with Acute Coronary Syndromes Treated with Ticagrelor or Clopidogrel in the PLATO Trial</a><div class="gs_gray">BM Scirica, CP Cannon, H Emanuelsson, RA Harrington, S Husted, ...</div><div class="gs_gray">Journal of the American College of Cardiology 55 (10S), A108. E1006-A108. E1006<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1251690485464278865" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:EYYDruWGBe4C" class="gsc_a_at">A Randomized Double-Blind Study to Assess the Onset and Offset of the Antiplatelet Effects of Ticagrelor versus Clopidogrel in Patients With Stable Coronary Artery Disease</a><div class="gs_gray">P Gurbel, K Bliden, K Butler, U Tantry, R Teng, M Antonino, SB Patil, ...</div><div class="gs_gray">Circulation 120 (suppl_18), S1143-S1143<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4542846961530922256" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">The Effect of Ticagrelor on Cardiopulmonary Function in Patients With Stable Coronary Artery Disease</a><div class="gs_gray">RF Storey, K Bliden, SB Patil, A Karunakaran, R Ecob, K Butler, R Teng, ...</div><div class="gs_gray">Circulation 120 (suppl_18), S1145-S1145<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=212566455320387135" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Antiplatelet therapy for acute coronary syndrome treated with percutaneous coronary intervention: new developments</a><div class="gs_gray">F FERNANDEZ-AVILES</div><div class="gs_gray">European heart journal supplements 11 (G)<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2082850515952709013" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Ticagrelor versus Clopidogrel in Acute Coronary Syndromes REPLY</a><div class="gs_gray">L Wallentin, H Emanuelsson, RA Harrington</div><div class="gs_gray">New England Journal of Medicine 361 (24), 2387-2388<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16915379080882987738" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:KUbvn5osdkgC" class="gsc_a_at">Clopidogrel therapy does not offset the platelet hypereactivity associated with common platelet receptor polymorphisms</a><div class="gs_gray">SMG Smith, HM Judge, G Peters, M Armstrong, P Fontana, P Gaussem, ...</div><div class="gs_gray">Haematologica 89 (Suppl 7), 11<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9987463188906685142" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Color Atlas of Neuroscience: Neuroanatomy and Neurophysiology by Ben Greenstein and Adam Greenstein</a><div class="gs_gray">E Storey</div><div class="gs_gray">INTERNATIONAL PSYCHOGERIATRICS 14 (3), 323-323<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=237508649396240466,16278464136914610894" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Influence of the ADP antagonists AR-C67085 and A2P5P on ADP-induced responses of platelets and isolated arteries</a><div class="gs_gray">E Glusa, RF Storey, HM Sanderson, S Heptinstall</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, 166-167<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11934623372501836816" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">The effects of a P-2T antagonist on platelet aggregation, platelet activation and platelet-leukocyte conjugate formation in vitro and following administration to patients with&nbsp;…</a><div class="gs_gray">HM Sanderson, RF Storey, RG Wilcox, S Heptinstall</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, 11-11<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5361790717233490414" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:MLfJN-KU85MC" class="gsc_a_at">In vitro effects of the novel platelet adenosine diphosphate receptor (P-2T) antagonist AR-C69931MX and aspirin on platelet aggregation in human whole blood: a potential new&nbsp;…</a><div class="gs_gray">RF Storey, J Glenn, S Heptinstall</div><div class="gs_gray">Circulation 98 (17), 560-560<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16911636274819711192" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:K4-iKlO5MD4C" class="gsc_a_at">Ticagrelor: clinical development and future potential</a><div class="gs_gray">NC Sanderson, WAE Parker, RF Storey</div><div class="gs_gray">Reviews in Cardiovascular Medicine 22 (2), 373-394<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17475572420600030259" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SrKkpNFED5gC" class="gsc_a_at">Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of&nbsp;…</a><div class="gs_gray">KA Krychtiuk, WS Speidl, E Giannitsis, B Gigante, DA Gorog, AS Jaffe, ...</div><div class="gs_gray">European Heart Journal Acute Cardiovascular Care 10 (3), 343-355<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9551570748598171737" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hefNtdE4IMkC" class="gsc_a_at">Genetic risk score to identify risk of venous thromboembolism in patients with cardiometabolic disease</a><div class="gs_gray">NA Marston, GEM Melloni, Y Gurmu, MP Bonaca, FK Kamanu, C Roselli, ...</div><div class="gs_gray">Circulation: Genomic and Precision Medicine 14 (1), e003006<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18247866966771008663" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:0ngZmJvimKcC" class="gsc_a_at">Regional variation in patients and outcomes in the GLOBAL LEADERS trial</a><div class="gs_gray">C Gao, K Takahashi, S Garg, H Hara, R Wang, H Kawashima, M Ono, ...</div><div class="gs_gray">International journal of cardiology 324, 30-37<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8963443556138780203" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:cB__R-XWw9UC" class="gsc_a_at">Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an&nbsp;…</a><div class="gs_gray">JP Collet, H Thiele, E Giannitsis, D Sibbing, O Barthélémy, J Bauersachs, ...</div><div class="gs_gray">European Heart Journal<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4517402873857419271" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:AFmTUeZ1pmEC" class="gsc_a_at">Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary&nbsp;…</a><div class="gs_gray">BW Hennigan, R Good, C Adamson, WAE Parker, L Martin, L Anderson, ...</div><div class="gs_gray">Platelets, 1-6<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13411795782264602458" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yIeBiWEAh44C" class="gsc_a_at">Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2&nbsp;…</a><div class="gs_gray">CC Everett, C Reynolds, C Fernandez, DD Stocken, LD Sharples, ...</div><div class="gs_gray">Diabetes and Vascular Disease Research 17 (5), 1479164120957934<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4679754102741263925" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:qsWQJNntlusC" class="gsc_a_at">Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial</a><div class="gs_gray">I Gregersen, AE Michelsen, NN Lunde, A Åkerblom, TG Lakic, M Skjelland, ...</div><div class="gs_gray">Journal of the American Heart Association 9 (17), e016360<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2498004200374905575" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Kqc1aDSOPooC" class="gsc_a_at">Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial</a><div class="gs_gray">RHM Furtado, RV Venkateswaran, JC Nicolau, Y Gurmu, DL Bhatt, ...</div><div class="gs_gray">Journal of the American Heart Association 9 (10), e015785<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11747548864503624032" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:v_tt_AnqfNMC" class="gsc_a_at">Apixaban versus warfarin and aspirin versus placebo according to renal function after acute coronary syndrome or PCI in atrial fibrillation: Insights from the AUGUSTUS trial</a><div class="gs_gray">Z Hijazi, JH Alexander, Z Li, D Wojdyla, R Mehran, CB Granger, MC Bahit, ...</div><div class="gs_gray">Journal of the American College of Cardiology 75 (11_Supplement_1), 298-298<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4423311157878645496" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:E7VqQtBCVmcC" class="gsc_a_at">Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable&nbsp;…</a><div class="gs_gray">RF Storey, PA Gurbel, S James, JM Ten Berg, JF Tanguay, C Bernaud, ...</div><div class="gs_gray">European Heart Journal 40, 1355-1355<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6061647098995235169" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hGdtkIFZdKAC" class="gsc_a_at">LONG-TERM SAFETY OF TICAGRELOR MONOTHERAPY IN PATIENTS UNDERGOING PCI FOR STABLE CORONARY ARTERY DISEASE IN THE GLOBAL LEADERS STUDY: IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY&nbsp;…</a><div class="gs_gray">M Tomaniak, P Chichareon, K Takahashi, N Kogame, R Modolo, ...</div><div class="gs_gray">Journal of the American College of Cardiology 73 (9S1), 196-196<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8525829235738998234" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:A8cqit5AE6sC" class="gsc_a_at">patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54</a><div class="gs_gray">MP Bonaca, RF Storey, DL Bhatt, PG Steg, M Cohen, KAP Im, P Johanson, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A16658-A16658<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17339242627222705444" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:L_l9e5I586QC" class="gsc_a_at">Patient selection for therapies to prevent major adverse limb events</a><div class="gs_gray">MP Bonaca, RP Giugliano, P Nault, BM Scirica, TR Pedersen, DL Bhatt, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A16771-A16771<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6563124985619990674" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:69ZgNCALVd0C" class="gsc_a_at">Ultra-low-dose twice-daily aspirin improves hemostasis and maintains platelet inhibition in acute coronary syndrome patients receiving ticagrelor</a><div class="gs_gray">W Parker, RC Orme, W Sumaya, J Hanson, H Stokes, H McMellon, ...</div><div class="gs_gray">Journal of the American College of Cardiology 71 (11S), A30-A30<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17923906202745045225" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:mWEH9CqjF64C" class="gsc_a_at">INHIBITORY MECHANISMS OF VERY LOW DOSE RIVAROXABAN IN NON-ST-ELEVATION MYOCARDIAL INFARCTION</a><div class="gs_gray">T Geisler, P Muenzer, N Alnaggar, S Geue, R Tegtmeyer, D Rath, ...</div><div class="gs_gray">Journal of the American College of Cardiology 71 (11S), A1398-A1398<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7410085311723908599" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">The challenges of antithrombotic therapy in patients with left ventricular thrombosis</a><div class="gs_gray">W Sumaya, RF Storey</div><div class="gs_gray">European heart journal<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14259836738291806145" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups</a><div class="gs_gray">EA Magnuson, MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, ...</div><div class="gs_gray">Journal of the American College of Cardiology 71 (1), 108-108<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8670004158122131244" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hfzGNhXhx5MC" class="gsc_a_at">Corrigendum to: Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era [Eur Heart J 2020; doi: 10.1093/eurheartj/ehaa409] In the originally&nbsp;…</a><div class="gs_gray">EE Ribeiro, R Mehran, CM Campos, Y Onuma, PA Lemos, PW Serruys, ...</div><div class="gs_gray">Cardiol 15, 480-496<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12598598856714305414" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:mKu_rENv82IC" class="gsc_a_at">Effect of Hypoglycemia on Platelet Reactivity and Platelet-Leukocyte Kinetics</a><div class="gs_gray">A Iqbal, M Thomas, P Novodvorsky, A Bernjak, L Birch, D Lambert, L Kay, ...</div><div class="gs_gray">Diabetes 66, A41-A41<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4737810291821020379" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:umqufdRvDiIC" class="gsc_a_at">72 Offset of ticagrelor prior to coronary artery bypass graft surgery (cabg) surgery</a><div class="gs_gray">KW Ow, M Thomas, W Parker, H Judge, R Storey</div><div class="gs_gray">Heart 103 (Suppl 5), A53-A54<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=821825745942140509" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LgRImbQfgY4C" class="gsc_a_at">Platelets in acute coronary syndromes</a><div class="gs_gray">MR Thomas, RF Storey</div><div class="gs_gray">Platelets in Thrombotic and Non-Thrombotic Disorders, 1015-1028<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9508313248299640250" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Long-Term Tolerability of Ticagrelor in the PEGASUS-TIMI 54 Trial</a><div class="gs_gray">MP Bonaca, DL Bhatt, TO Ophuis, PG Steg, R Storey, M Cohen, J Kuder, ...</div><div class="gs_gray">CIRCULATION 132 (23), 2272-2272<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10833809304128885006" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Reduction in total cardiovascular events with long-term use of ticagrelor in patients with prior myocardial infarction in the PEGASUS-TIMI 54 trial</a><div class="gs_gray">SA Murphy, MP Bonaca, S Goto, DL Bhatt, PG Steg, RF Storey, ...</div><div class="gs_gray">Circulation 132 (suppl_3), A17121-A17121<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11474541640044557977" class="gsc_a_ac gs_ibl gsc_a_acm" data-eid="-plVGtcAAAAJ:yqoGN6RLRZoC" data-eud="-plVGtcAAAAJ:hCrLmN-GePgC">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Reduction in total cardiovascular events with long-term use of ticagrelor in patients with prior myocardial infarction in the PEGASUS-TIMI 54 trial</a><div class="gs_gray">SA Murphy, MP Bonaca, S Goto, DL Bhatt, PG Steg, RF Storey, ...</div><div class="gs_gray">Circulation 132 (suppl_3), A17121-A17121<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11474541640044557977" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY</a><div class="gs_gray">J Silvain, R Storey, G Cayla, JB Esteve, JG Dillinger, E Vicat, JP Collet, ...</div><div class="gs_gray">Journal of the American College of Cardiology 65 (10S), A221-A221<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=770893294649124217" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Reply: Triple Therapy for Atrial Fibrillation and ACS With or Without PCI: Don't Drop Aspirin Just Yet</a><div class="gs_gray">WJM Dewilde, PWA Janssen, FWA Verheugt, RF Storey, T Adriaenssens, ...</div><div class="gs_gray">Journal of the American College of Cardiology 65 (5), 516-518<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3672681530353593240" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Plasma microRNA levels in patients with acute coronary syndrome are associated with platelet function</a><div class="gs_gray">L Bender, M Mayr, D Kaudewitz, P Skroblin, P Willeit, A Morton, F Gracio, ...</div><div class="gs_gray">Atherosclerosis 237 (2), e5<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5163439603333722825" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LhH-TYMQEocC" class="gsc_a_at">Lower mortality and stent thrombosis rates associated with introduction of potent P2Y12 inhibitors in patients with acute coronary syndromes</a><div class="gs_gray">J Iqbal, R Rowe, YJ Zhang, Y Parviz, AC Morton, E Grech, JP Gunn, ...</div><div class="gs_gray">Circulation 130 (suppl_2), A20470-A20470<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5211126851190430822" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Plasma MicroRNAs correlate with platelet reactivity in patients with acute coronary syndrome: association with platelet function</a><div class="gs_gray">M Mayr, D Kaudewitz, P Skroblin, P Willeit, A Zampetaki, AC Morton, ...</div><div class="gs_gray">Circulation 130 (suppl_2), A20657-A20657<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11875712716242994446" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS: Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial</a><div class="gs_gray">P Tricoci, E Chen, ML Neely, A Warner, PH Wong, P Sinnaeve, ...</div><div class="gs_gray">Circulation 128 (suppl_22), A17658-A17658<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14630452264053552053" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Are There Any Causal Relations Between Growth Differentiation Factor 15 and Outcomes in Patients With Acute Coronary Syndrome?-A Report From the Plato Gwas Study</a><div class="gs_gray">E Hagström, N Eriksson, åsa Johansson, M Bertilsson, T Axelsson, ...</div><div class="gs_gray">Circulation 128 (suppl_22), A17372-A17372<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7735964449093466850" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:anf4URPfarAC" class="gsc_a_at">Health economic evaluation of ticagrelor compared to generic clopidogrel in patients with acute coronary syndromes intended for non-invasive management based on the PLATO trial</a><div class="gs_gray">S James, RF Storey, C Cannon, M Janzon, JC Nicolau, B Parasuraman, ...</div><div class="gs_gray">European Heart Journal 34 (suppl_1)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18227722679951897106" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:8d8msizDQcsC" class="gsc_a_at">GDF-15 level in acute coronary syndrome and its relations to cardiovascular risk factors, disease manifestations, treatments and outcome-results from the PLATO-study</a><div class="gs_gray">LC Wallentin, M Bertilsson, RC Becker, A Himmelmann, S Husted, ...</div><div class="gs_gray">European Heart Journal 34 (suppl_1)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18086045463427192099" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Ischaemic events following planned discontinuation of study treatment with ticagrelor or clopidogrel in the PLATO study</a><div class="gs_gray">RF Storey, D Ardissino, L Vignali, R Cairns, RC Becker, CP Cannon, ...</div><div class="gs_gray">European Heart Journal 34 (suppl_1)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6904200215875331663" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">PAR-1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact: PA 4.01–3</a><div class="gs_gray">H Judge, L Jennings, D Moliterno, E Hord, R Ecob, P Tricoci, S Smyth, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8812043917125942821" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:_axFR9aDTf0C" class="gsc_a_at">265 PLASMA MICRORNAS AS BIOMARKERS FOR PLATELET INHIBITION</a><div class="gs_gray">P Willeit, A Zampetaki, D Kaudewitz, R Lee, K Dudek, A King, NS Kirkby, ...</div><div class="gs_gray">Heart 99 (suppl 2), A139-A140<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12210678365367046860" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">An International Perspective of Current Patterns of Antiplatelet Drug Use in Acute Coronary Syndrome Patients. Results from the EPICOR Study</a><div class="gs_gray">H Bueno, RF Storey, N Danchin, JI Sánchez-Coviza, M Licour, ...</div><div class="gs_gray">Circulation 126 (suppl_21), A11821-A11821<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9813217493077309979" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Response to Letter Regarding Article,“Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor: Insights From PLATO”</a><div class="gs_gray">SG Goodman, R Clare, KS Pieper, KW Mahaffey, RA Harrington, ...</div><div class="gs_gray">Circulation 126 (11), e171-e172<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13756158929761840309" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">USEFULNESS OF BIOMARKERS FOR PROGNOSTICATION OF OUTCOME WITH EARLY INVASIVE OR NONINVASIVE TREATMENT IN NON-ST-ELEVATION ACUTE CORONARY SYNDROMES–A SUBSTUDY FROM THE&nbsp;…</a><div class="gs_gray">L Wallentin, S James, E Giannitsis, H Katus, R Becker, C Cannon, ...</div><div class="gs_gray">Journal of the American College of Cardiology 59 (13S), E497-E497<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7460552659319607664" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Reduction in first and recurrent cardiovascular and ischemic events with ticagrelor compared with clopidogrel in the PLATO study</a><div class="gs_gray">P Kohli, L Wallentin, E Reyes, J Horrow, S Husted, R Storey, S James, ...</div><div class="gs_gray">Journal of the American College of Cardiology 59 (13S), E504-E504<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6269213594862475534" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:FAceZFleit8C" class="gsc_a_at">Contemporary management of ST-segment elevation myocardial infarction</a><div class="gs_gray">A Karunakaran, W Sumaya, JP Gunn, AC Morton, RF Storey</div><div class="gs_gray">Hospital practice 40 (1), 224-231<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17271876186390927503" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Рекомендации по лечению острого коронарного синдрома без стойкого подъема сегмента ST</a><div class="gs_gray">B Jean-Pierre, A Stefan, B Jeroen, B Eric, B Hector, C Pio, D Dariusz, ...</div><div class="gs_gray">Рациональная фармакотерапия в кардиологии 8 (2s)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14528184998668371275,5052033977390697423" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Republished Education in Heart: New P2Y12 inhibitors</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Postgraduate medical journal 88 (1035), 49-54<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16675574740302547623" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: Results from the Platelet Inhibition and Patient&nbsp;…</a><div class="gs_gray">SK James, RF Storey, C Bushnell, J Horrow, S Husted, KW Mahaffey, ...</div><div class="gs_gray">Circulation 124 (suppl_21), A15029-A15029<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11435553971255805805" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Serial renal function assessment with cystatin c in patients with acute coronary syndrome randomized to ticagrelor or clopidogrel</a><div class="gs_gray">A Akerblom, L Wallentin, A Siegbahn, A Budaj, J Horrow, S Husted, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 32, 417-417<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6239261291772749391" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:YohjEiUPhakC" class="gsc_a_at">CYSTATIN C IS AN INDEPENDENT RISK PREDICTOR FOR DEATH OR MYOCARDIAL INFARCTION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) AS WELL AS IN NON-ST-ELEVATION ACUTE&nbsp;…</a><div class="gs_gray">A Åkerblom, L Wallentin, A Siegbahn, RC Becker, A Budaj, K Buck, ...</div><div class="gs_gray">Journal of the American College of Cardiology 57 (14S), E999-E999<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14122653102167117041" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Руководство по лечению дислипидемий</a><div class="gs_gray">Z Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">Атеросклероз и дислипидемии<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4571606566483182354" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Education in atherothrombosis</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Thrombosis and haemostasis 105 (S 06), S1-S2<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11689654210273984108" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes The PLATO (PLATelet inhibition and patient Outcomes&nbsp;…</a><div class="gs_gray">RF Storey, DJ Angiolillo, SB Patil</div><div class="gs_gray">JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 56 (22), 1895-1895<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7786805010703838879" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Platelet inhibition by ticagrelor is not affected by proton pump inhibitors: results from the PLATO PLATELET substudy</a><div class="gs_gray">SB Patil, DJ Angiolillo, B Desai, R Ecob, S Husted, H Emanuelsson, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 31, 905-906<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16984798570716756367" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Maintenance treatment with ticagrelor yields greater and more consistent inhibition of platelet function compared to clopidogrel in patients with acute coronary syndromes&nbsp;…</a><div class="gs_gray">RF Storey, DJ Angiolillo, SB Patil, B Desai, S Husted, H Emanuelsson, ...</div><div class="gs_gray">Circulation 120 (suppl_18), S1027-S1027<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16574550572995129026" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:foquWX3nUaYC" class="gsc_a_at">More rapid and consistent inhibition of platelet aggregation is achieved by loading with ticagrelor compared to clopidogrel in patients with acute coronary syndromes: results&nbsp;…</a><div class="gs_gray">RF Storey, SB Patil, R Ecob, DJ Angiolillo, L Wallentin</div><div class="gs_gray">Circulation 120 (suppl_18), S1102-S1102<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8599064003042708200" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:j5aT6aphRxQC" class="gsc_a_at">Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non-ST&nbsp;…</a><div class="gs_gray">I DISPERSE-2, CP Cannon, S Husted, RA Harrington, BM Scirica, ...</div><div class="gs_gray">Journal of the American College of Cardiology 50 (19), 1844-1851<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2328078399034485028" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:7VEv-pLvLSsC" class="gsc_a_at">The effects of AZD6140, the first oral reversible ADP receptor antagonist, compared with clopidogrel on biochemical markers in patients with acute coronary syndromes (ACS)</a><div class="gs_gray">S Husted, RF Storey, RA Harrington, N Sanders, G Peters, ...</div><div class="gs_gray">JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 200A-200A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8562324324771564630" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Heparins sensitize platelets to responses mediated via both the P-2T and the P2Y (1) receptor pathways</a><div class="gs_gray">RF Storey, JA May, S Heptinstall</div><div class="gs_gray">Circulation 100 (18), 680-680<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16319073106700737351" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-FonjvnnhkoC" class="gsc_a_at">The central role of the P-2T receptor in amplification of platelet aggregation and secretion</a><div class="gs_gray">RF Storey, A White, JA May, LJ Newby, S Heptinstall</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, 420-420<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2503280839271996226" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Administration of a GPIIb/IIIa antagonist to patients with unstable angina: Effects on platelet aggregation and platelet-leucocyte conjugate formation</a><div class="gs_gray">HM Sanderson, RF Storey, S Heptinstall</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, 357-358<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14918340307672679721" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:DIubQTN3OvUC" class="gsc_a_at">Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial</a><div class="gs_gray">BA Bergmark, DL Bhatt, PG Steg, A Budaj, RF Storey, Y Gurmu, JF Kuder, ...</div><div class="gs_gray">Journal of the American Heart Association 10 (17), e020446<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:a2necdfpwlEC" class="gsc_a_at">Ticagrelor monotherapy in CKD: better safety at what price?</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">European Heart Journal<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:S2WlVNSe3u4C" class="gsc_a_at">Aspirin dosing for atherosclerotic cardiovascular disease: should we be more ADAPTABLE?</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray">Cardiovascular Research 117 (10), e123-e125<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:eFf2swCANGcC" class="gsc_a_at">Selatogrel and other P2Y12 inhibitors’ putative off-target effects</a><div class="gs_gray">M Valgimigli, RF Storey, PR Sinnaeve, MA Riederer, C Bernaud, ...</div><div class="gs_gray">Journal of Cardiovascular Pharmacology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:oYLFIHfuHKwC" class="gsc_a_at">Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi‐country observational study</a><div class="gs_gray">E Lesén, C Hewitt, E Giannitsis, J Hedberg, T Jernberg, D Lambrelli, ...</div><div class="gs_gray">Clinical Cardiology<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:cSdaV2aYdYsC" class="gsc_a_at">Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment–Elevation Myocardial Infarction: Insights From the COMPLETE Trial</a><div class="gs_gray">P Dehghani, WJ Cantor, J Wang, DA Wood, RF Storey, R Mehran, ...</div><div class="gs_gray">Circulation: Cardiovascular Interventions 14 (8), e010458<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:NtCmTCuxid4C" class="gsc_a_at">Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk</a><div class="gs_gray">RJ King, K Schuett, C Tiede, V Jankowski, V John, A Trehan, K Simmons, ...</div><div class="gs_gray">Haematologica 106 (6), 1616<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:T8_be82Iz5gC" class="gsc_a_at">International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests</a><div class="gs_gray">PA Gurbel, US Tantry, RF Storey</div><div class="gs_gray">Journal of Thrombosis and Thrombolysis, 1-7<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:qPeb-qHga9sC" class="gsc_a_at">COMPLETE REVASCULARIZATION IN PATIENTS UNDERGOING A PHARMACOINVASIVE STRATEGY FOR STEMI</a><div class="gs_gray">P Dehghani, W Cantor, J Wang, D Wood, R Storey, R Mehran, K Bainey, ...</div><div class="gs_gray">Journal of the American College of Cardiology 77 (18_Supplement_1), 933-933<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:CMvovTBb2okC" class="gsc_a_at">The simultaneous and anticoagulant conundrum antiplatelet of therapy: how to solve it?</a><div class="gs_gray">FWA Verheugt, RF Storey</div><div class="gs_gray">Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease, 193<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:9LpHyFPp1DQC" class="gsc_a_at">The authors have no conflicts of interest to disclose.</a><div class="gs_gray">EH CP, C Held, J Horrow, S Husted, S James, H Katus, KW Mahaffey, ...</div><div class="gs_gray">Am J Cardiol 143 (160), 0002-9149<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:3vbIHxFL9FgC" class="gsc_a_at">Non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta‐analysis</a><div class="gs_gray">S Al Said, S Alabed, W Sumaya, D Alsaid, K Kaier, D Duerschmied, ...</div><div class="gs_gray">Cochrane Database of Systematic Reviews<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:8uzoZH4hB9AC" class="gsc_a_at">The conundrum of simultaneous antiplatelet and anticoagulant therapy: how to solve it?</a><div class="gs_gray">FWA Verheugt, RF Storey</div><div class="gs_gray">Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease, 193-199<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:X5YyAB84Iw4C" class="gsc_a_at">Rapid Assessment of Potential Ischaemic Heart Disease With Ctca: The Rapid-ctca Trial. A Randomised Trial of Ctcain the Evaluation, Intervention and Outcome Ofadults With&nbsp;…</a><div class="gs_gray">AJ Gray, C Roobottom, JE Smith, S Goodacre, K Oatey, RF Storey, ...</div><div class="gs_gray">CIRCULATION 142 (24), E471-E472<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:u3T1itk59dMC" class="gsc_a_at">A Novel Genetic Risk Score Predicts Ischemic Stroke in Patients With Cardiometabolic Disease</a><div class="gs_gray">PN Patel, NA Marston, FK Kamanu, LC Weng, MP Bonaca, RP Giugliano, ...</div><div class="gs_gray">Circulation 142 (Suppl_3), A13702-A13702<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:EBV337fEn3EC" class="gsc_a_at">The Cardiac Complications of COVID-19; Many Publications, Multiple Uncertainties</a><div class="gs_gray">A Al-Mohammad, DG Partridge, G Fent, O Watson, NT Lewis, RF Storey, ...</div><div class="gs_gray">Vascular Biology 1 (aop)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:l6Q3WhenKVUC" class="gsc_a_at">Rationale, design and feasibility of conducting a real-world study of outcomes in patients with a history of MI receiving extended DAPT with ticagrelor 60 mg</a><div class="gs_gray">E Lesen, C Hewitt, E Giannitsis, J Hedberg, T Jernberg, D Lambrelli, ...</div><div class="gs_gray">PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 129-129<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:V_vSwabWVtYC" class="gsc_a_at">113 Potential role of coronary physiology in treating ‘bystander’disease in patients with ST-elevation myocardial infarction</a><div class="gs_gray">M Knight, V Rammohan, A Preston, G Williams, M Ghobrial, A Al Baraikan, ...</div><div class="gs_gray">Heart 106 (Suppl 2), A93-A94<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:e84hm74t-eoC" class="gsc_a_at">51 Adherence to cardiologist recommendations regarding extended duration of ticagrelor for patients undergoing PCI for myocardial infarction</a><div class="gs_gray">KW Ow, W Parker, E Onwordi, RF Storey</div><div class="gs_gray">Heart 106 (Suppl 2), A41-A41<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:w2UhwfzvF0QC" class="gsc_a_at">2019 ESC Guide on the Diagnosis and Treatment of Chronic Coronary Syndromes</a><div class="gs_gray">J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ...</div><div class="gs_gray">REVISTA ESPANOLA DE CARDIOLOGIA 73 (6)<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:RXiHnyRawswC" class="gsc_a_at">PERFORMANCE OF A NOVEL GENETIC RISK SCORE TO IDENTIFY RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CARDIOMETABOLIC DISEASE</a><div class="gs_gray">N Marston, G Melloni, Y Gurmu, C Lee, F Kamanu, C Roselli, MP Bonaca, ...</div><div class="gs_gray">Journal of the American College of Cardiology 75 (11_Supplement_1), 2194-2194<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Gpwnp1kGG20C" class="gsc_a_at">Wytyczne ESC dotyczące rozpoznawania i leczenia przewlekłych zespołów wieńcowych (2019)</a><div class="gs_gray">J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ...</div><div class="gs_gray">Kardiologia Polska (Polish Heart Journal) 78 (I), 10-87<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:wuD5JclIwkYC" class="gsc_a_at">Wytyczne ESC dotyczące rozpoznawania i leczenia przewlekłych zespołów wieńcowych (2019). Dane uzupełniające</a><div class="gs_gray">J Knuuti, W Wijns, A Saraste, D Capodanno, E Barbato, ...</div><div class="gs_gray">Kardiologia Polska (Polish Heart Journal) 78 (I), 1-21<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:lK9BDNCuzFgC" class="gsc_a_at">Tricuspid Regurgitation: Understanding the “Problem Child” Saul G. Myerson 1302</a><div class="gs_gray">T Sheth, N Pinilla-echeverri, R Moreno, J Wang, DA Wood, RF Storey, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:h168fVGZblEC" class="gsc_a_at">Non-Culprit Lesion Plaque Morphology in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Trial Optical Coherence Tomography (OCT) Substudy</a><div class="gs_gray">NP Echeverri, SR Mehta, J Wang, S Lavi, DA Wood, W Cantor, KR Bainey, ...</div><div class="gs_gray">CIRCULATION 140 (25), E982-E983<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:3_LpOwP6eMYC" class="gsc_a_at">Prolonged Enoxaparin Infusion in Patients Undergoing Primary Percutaneous Coronary Intervention Compared to Standard-of-care: A Single-centre Clinical Trial</a><div class="gs_gray">W Sumaya, W Parker, HM Judge, IR Hall, RC Orme, Z Adam, ...</div><div class="gs_gray">Circulation 140 (Suppl_1), A10426-A10426<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:TesyEGJKHF4C" class="gsc_a_at">Novel <i>CYP2C19</i> Genetic Variants Associated With Stent Thrombosis - A Next Generation Sequencing Study</a><div class="gs_gray">L Zhang, JA Morales-Rosado, K Goel, A Akerblom, S Baheti, J Black, ...</div><div class="gs_gray">Circulation 140 (Suppl_1), A14397-A14397<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:JH5k92_tO-AC" class="gsc_a_at">Dyspnea in ticagrelor treated patients in the all-comer randomized GLOBAL LEADERS study and its association with clinical outcomes</a><div class="gs_gray">M Tomaniak, P Chichareon, R Modolo, S Plante, P Brunel, F Beygui, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 40, 4011-4011<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:natZJ_-F0IUC" class="gsc_a_at">TCT-404 Benefit and Risks of Aspirin on Top of Ticagrelor in Acute Coronary Syndromes: Insights From the Randomized GLOBAL LEADERS Trial</a><div class="gs_gray">M Tomaniak, P Chichareon, Y Onuma, E Deliargyris, K Takahashi, ...</div><div class="gs_gray">Journal of the American College of Cardiology 74 (13S), B400-B400<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Azgs6IHzeyYC" class="gsc_a_at">2349 Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in&nbsp;…</a><div class="gs_gray">RF Storey, PA Gurbel, S James, JM Ten Berg, JF Tanguay, C Bernaud, ...</div><div class="gs_gray">European Heart Journal 40 (Supplement_1), ehz748. 0136<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:xm0LlTxljI0C" class="gsc_a_at">P6411 Dyspnea in ticagrelor treated patients in the all-comer randomized GLOBAL LEADERS study and its association with clinical outcomes</a><div class="gs_gray">M Tomaniak, P Chichareon, R Modolo, S Plante, P Brunel, F Beygui, ...</div><div class="gs_gray">European Heart Journal 40 (Supplement_1), ehz746. 1005<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sJK75vZXtG0C" class="gsc_a_at">Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes</a><div class="gs_gray">A Åkerblom, D Wojdyla, PG Steg, L Wallentin, SK James, A Budaj, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:jmjb1lOE9QIC" class="gsc_a_at">Does Risk of Premature Discontinuation of Dual-Antiplatelet Therapy Following PCI Attenuate With Increasing Age?</a><div class="gs_gray">W Sumaya, RF Storey</div><div class="gs_gray">JACC: Cardiovascular Interventions 12 (10), 993-994<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:txeM2kYbVNMC" class="gsc_a_at">considered too high and may be favored over surgery.</a><div class="gs_gray">DA Wood, JA Cairns, J Wang, R Mehran, RF Storey, H Nguyen, B Meeks, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:MIg0yeAD4ggC" class="gsc_a_at">Caffeine and Dyspnea With Ticagrelor: A Sub-Analysis From PEGASUS TIMI-54 Trial</a><div class="gs_gray">RH Furtado, R Venkateswaran, DL Bhatt, RF Storey, PG Steg, M Cohen, ...</div><div class="gs_gray">Circulation 138 (Suppl_1), A14143-A14143<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-yGd096yOn8C" class="gsc_a_at">Acute hypoglycaemia results in increased activation of responses to an inflammatory challenge induced 48 hours later in human subjects</a><div class="gs_gray">A Iqbal, L Prince, P Novodvorsky, A Bernjak, M Thomas, L Birch, ...</div><div class="gs_gray">DIABETOLOGIA 61, S446-S446<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:YTuZlYwrTOUC" class="gsc_a_at">Multiple biomarkers and cause-specific mortality in patients with acute coronary syndromes-Insights from the PLATO biomarker substudy</a><div class="gs_gray">D Lindholm, S James, K Gabrysch, RF Storey, A Himmelmann, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 39, 145-146<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:wE-fMHVdjMkC" class="gsc_a_at">P823 Multiple biomarkers and cause-specific mortality in patients with acute coronary syndromes-Insights from the PLATO biomarker substudy</a><div class="gs_gray">D Lindholm, S James, K Gabrysch, RF Storey, A Himmelmann, ...</div><div class="gs_gray">European Heart Journal 39 (suppl_1), ehy564. P823<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kJDgFkosVoMC" class="gsc_a_at">P4404 Impaired fibrin clot lysis persists at 1 month post ACS: a PLATO substudy</a><div class="gs_gray">W Sumaya, L Wallentin, SK James, A Siegbahn, K Gabrysch, ...</div><div class="gs_gray">European Heart Journal 39 (suppl_1), ehy563. P4404<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:jSAVyFp_754C" class="gsc_a_at">Response by Angiolillo et al to Letter Regarding Article, “International Expert Consensus Document on Switching Platelet P2Y<sub>12</sub> Receptor Inhibiting Therapies”</a><div class="gs_gray">DJ Angiolillo, MJ Price, RF Storey</div><div class="gs_gray">Circulation 137 (21), 2310-2311<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SGW5VrABaM0C" class="gsc_a_at">Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study</a><div class="gs_gray">RF Storey, D Ardissino, L Vignali, R Cairns, RC Becker, CP Cannon, ...</div><div class="gs_gray">Thrombosis and haemostasis 118 (02), 427-429<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery DiseaseThe Task Force for the Management of Dual Antiplatelet Therapy&nbsp;…</a><div class="gs_gray">JP Collet, M Roffi, RA Byrne, F Costa, M Valgimigli, H Bueno, A Jeppsson, ...</div><div class="gs_gray">European Heart Journal<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Adverse Fibrin Clot Properties Are Associated With Worse Outcome Following Acute Coronary Syndrome: A PLATO Substudy</a><div class="gs_gray">W Sumaya, L Wallentin, SK James, A Siegbahn, K Gabrysch, M Bertilsson, ...</div><div class="gs_gray">Circulation 136 (suppl_1), A14539-A14539<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kWvqk_afx_IC" class="gsc_a_at">Hypoglycaemia increases platelet reactivity and promotes formation of proatherogenic platelet-leucocyte aggregates</a><div class="gs_gray">A Iqbal, M Thomas, P Novodvorsky, A Bernjak, L Birch, D Lambert, L Kay, ...</div><div class="gs_gray">DIABETOLOGIA 60, S532-S532<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:NDuN12AVoxsC" class="gsc_a_at">2864Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54</a><div class="gs_gray">M Bonaca, P Jarolim, EL Goodrich, RF Storey, DL Bhatt, PG Steg, ...</div><div class="gs_gray">European Heart Journal 38 (suppl_1)<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Antiplatelet Therapy in Noncardioembolic Stroke: A Review of Current Evidence</a><div class="gs_gray">K Krishnan, M Jusufovic, PM Sandset, EC Sandset</div><div class="gs_gray">Seminars in neurology 37 (03), 366-375<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:kF1pexMAQbMC" class="gsc_a_at">COMPARISON OF P2Y12 INHIBITORS FOR MORTALITY AND STENT THROMBOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES: SINGLE CENTRE STUDY OF 10,793 CONSECUTIVE ‘REAL-WORLD’PATIENTS</a><div class="gs_gray">R Gosling, M Yazdani, Y Parviz, I Hall, E Grech, J Gunn, R Storey, J Iqbal</div><div class="gs_gray">Journal of the American College of Cardiology 69 (11S), 1014-1014<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Steen Elkjær Husted MD FESC 1950–2016</a><div class="gs_gray">RF Storey, JC Morais, B Rocca</div><div class="gs_gray">European Heart Journal 38 (7), 472-472<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-uzm3Y7AvW0C" class="gsc_a_at">Gregory YH Lip*, Jean Philippe Collet 2, Raffaele de Caterina 3, Laurent Fauchier 4, Deirdre A. Lane 5, Torben B. Larsen 6, Francisco Marin 7, Joao Morais 8, Calambur&nbsp;…</a><div class="gs_gray">G Vilahur, T Weiss, G Boriani, B Rocca, I Savelieva, C Sticherling, ...</div><div class="gs_gray">Europace 19, 1757-1758<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Ehil0879vHcC" class="gsc_a_at">Impact of medication on quantification of plasma MicroRNAs in patients with cardiovascular disease</a><div class="gs_gray">D Kaudewitz</div><div class="gs_gray">lmu<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:G1UMdFYMoxkC" class="gsc_a_at">2015 ESC Guidelines for the treatment of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Treatment of Acute Coronary&nbsp;…</a><div class="gs_gray">M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, DP Chew, ...</div><div class="gs_gray">GIORNALE ITALIANO DI CARDIOLOGIA 17 (10), 831-872<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ShjGdcaqzI0C" class="gsc_a_at">Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction</a><div class="gs_gray">R Storey</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:wKETBy42zhYC" class="gsc_a_at">Platelet P2Y12 inhibitors enhance expansion of the intermediate monocyte population following systemic inflammation in humans</a><div class="gs_gray">MR Thomas, A Iqbal, SN Outteridge, HM Judge, DH Dockrell, I Sabroe, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 37, 904-904<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: the ATLANTIC ST-segment resolution substudy</a><div class="gs_gray">AW van't Hof, E Fabris, F Giannini, J Silvain, H Rousseau, E Vicaut, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 37, 1173-1173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:fFSKOagxvKUC" class="gsc_a_at">Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetic status</a><div class="gs_gray">MR Thomas, DJ Angiolillo, MP Bonaca, HM Judge, F Rollini, F Franchi, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 37, 1161-1161<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yFnVuubrUp4C" class="gsc_a_at">27 Impact of Culprit Versus Non-Culprit Angiography Strategy on Primary PCI Door to Balloon Times</a><div class="gs_gray">A Horne, J Gunn, J Iqbal, K Morgan, I Hall, J West, E Grech, D Barmby, ...</div><div class="gs_gray">Heart 102 (Suppl 6), A18-A18<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:q-HalDI95KYC" class="gsc_a_at">Serum Uric Acid Is Associated With Cardiovascular Outcomes In Patients With Acute Coronary Syndromes: Results From The Platelet Inhibition And Patient Outcomes (Plato) Trial</a><div class="gs_gray">A Åkerblom, S James, M Bertilsson, A Himmelmann, M Huhn, K Pieper, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (13S), 556-556<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Prediction Of Major Bleeding In Revascularized Patients With Acute Coronary Syndromes: Development Of A Novel Biomarker-Based Clinical Prediction Model</a><div class="gs_gray">D Lindholm, J Lindbäck, S James, R Becker, J Cornel, A Himmelmann, ...</div><div class="gs_gray">Journal of the American College of Cardiology 67 (13S), 493-493<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:8xutWZnSdmoC" class="gsc_a_at">CRT-200.62 The Impact of Ticagrelor on Platelet Reactivity in African Americans: Interim Results of the ACS Ethnicity Study</a><div class="gs_gray">MJ Lipinski, MA Gaglia, T Lhermusier, A Steinvil, S Kiramijyan, ...</div><div class="gs_gray">JACC: Cardiovascular Interventions 9 (4S), S22-S22<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Alasdair J. Gray1, 2, Carl Roobottom4, 5, Jason E. Smith4, 5, 6, Steve Goodacre7, Katherine Oatey3, Rachel O’Brien1</a><div class="gs_gray">RF Storey, L Na, SC Lewis, P Thokala, DE Newby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Successful reperfusion is associated with lower levels of markers of myocardial damage and dysfunction in ST-elevation but not in non-ST-elevation myocardial infarction&nbsp;…</a><div class="gs_gray">C Varenhorst, A Åkerblom, H Renlund, V Kunadian, SK James, PG Steg, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 37, 1282-1283<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Potential role of ticagrelor in preventing venous and cardiac thrombosis: insights from PEGASUS-TIMI 54</a><div class="gs_gray">I Cavallari, P Aylward, PG Steg, RF Storey, DL Bhatt, M Cohen, A Budaj, ...</div><div class="gs_gray">European Heart Journal 37 (S1), 636-637<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">Platelet P2Y</a><div class="gs_gray">MR Thomas, SN Outteridge, RA Ajjan, F Phoenix, GK Sangha, ...</div><div class="gs_gray">Arterioscler Thromb Vasc Biol<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">GDF-15 at One Month After an Acute Coronary Syndrome is Associated With Increased Risk of Major Bleeding-A PLATO Biomarker Substudy</a><div class="gs_gray">D Lindholm, E Hagström, SK James, RC Becker, CP Cannon, ...</div><div class="gs_gray">Circulation 132 (suppl_3), A13290-A13290<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:0CzhzZyukY4C" class="gsc_a_at">Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study</a><div class="gs_gray">RF Storey, DL Bhatt, PG Steg, GW Stone, HD White, CM Gibson, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 36, 237-237<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Associations of plasma microRNAs with platelet proteins and platelet function</a><div class="gs_gray">D Kaudewitz, P Skroblin, K Willeit, P Willeit, T Barwari, A Zampetaki, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 36, 230-230<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Pre-hospital ticagrelor in ST-segment elevation myocardial infarction: the French subgroup analysis of the ATLANTIC study</a><div class="gs_gray">G Cayla, F Lapostolle, CJ Hammett, B Merkely, JF Lassen, RF Storey, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 36, 68-68<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:eI34FqJmdUoC" class="gsc_a_at">TICAGRELOR AND CLOPIDOGREL ATTENUATE THE PROTHROMBOTIC STATE INDUCED BY BACTERIAL ENDOTOXAEMIA</a><div class="gs_gray">M Thomas, R Ajjan, F Phoenix, S Outteridge, D Dockrell, I Sabroe, ...</div><div class="gs_gray">HEART 101, A112-A112<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Prasugrel monotherapy provides most effective platelet inhibition without affecting fibrin clot dynamics in individuals with diabetes: OR398</a><div class="gs_gray">R Storey, N Oxley, F Phoenix, Z Kurdee, R King, M Zabczyk, P Grant, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:1taIhTC69MYC" class="gsc_a_at">Ticagrelor and clopidogrel attenuate the prothrombotic state induced by bacterial endotoxemia: OR016</a><div class="gs_gray">M Thomas, R Ajjan, F Phoenix, S Outteridge, H Judge, D Dockrell, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:lvd772isFD0C" class="gsc_a_at">203 Ticagrelor and Clopidogrel Attenuate the Prothrombotic State induced by Bacterial Endotoxaemia</a><div class="gs_gray">M Thomas, R Ajjan, F Phoenix, S Outteridge, D Dockrell, I Sabroe, ...</div><div class="gs_gray">Heart 101 (Suppl 4), A112-A112<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Ticagrelor and clopidogrel attenuate the prothrombotic state induced by bacterial endotoxemia: OR016</a><div class="gs_gray">M Thomas, R Ajjan, F Phoenix, S Outteridge, H Judge, D Dockrell, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 13<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">GENDER DIFFERENCE IN CHANGES OF PLAQUE CHARACTERISTICS IN RESPONSE TO INTENSIVE LIPID-LOWERING THERAPY: SERIAL OPTICAL COHERENCE TOMOGRAPHY AND INTRAVASCULAR ULTRASOUND ANALYSIS</a><div class="gs_gray">Y Minami, J Hou, H Jia, S Hu, R Vergallo, T Soeda, S Zhang, B Yu, ...</div><div class="gs_gray">Journal of the American College of Cardiology 65 (10S), A210-A210<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ODE9OILHJdcC" class="gsc_a_at">TICAGRELOR POTENTIATES NEUTROPHIL PHAGOCYTOSIS VIA INHIBITION OF ADENOSINE REUPTAKE BY ERYTHROCYTES</a><div class="gs_gray">MR Thomas, KF Alsharif, LR Prince, VC Ridger, HM Judge, DH Dockrell, ...</div><div class="gs_gray">Journal of the American College of Cardiology 65 (10S), A259-A259<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:CdxZDUztZiMC" class="gsc_a_at">Balancing the risk of ischaemic and bleeding events in ACS</a><div class="gs_gray">G Ducrocq, PJ Schulte, A Budaj, JH Cornel, C Held, A Himmelmann, ...</div><div class="gs_gray">European Heart Journal 36 (Suppl. 1), 860-861<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">Development of a novel biomarker-based clinical prediction model for major adverse cardiovascular events in revascularized patients with acute coronary syndromes</a><div class="gs_gray">D Lindholm, J Lindbäck, S James, RC Becker, JH Cornel, A Himmelmann, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Zh0EY9V9P6UC" class="gsc_a_at">Ticagrelor inhibits release of pro-inflammatory cytokines TNF and IL-6 during human endotoxaemia</a><div class="gs_gray">MR Thomas, SN Outteridge, R Ecob, GK Sangha, RE Faulkner, LE West, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 35, 1170-1170<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Ticagrelor and dipyridamole potentiate adenosine-induced stimulation of neutrophil chemotaxis in the presence of erythrocytes</a><div class="gs_gray">K Alsharif, H Judge, V Ridger, RF Storey</div><div class="gs_gray">EUROPEAN HEART JOURNAL 35, 1031-1032<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">RISK OF CARDIOVASCULAR DEATH AND NON-SUSTAINED VENTRICULAR TACHYCARDIA DETECTED 30-DAYS AFTER ACUTE CORONARY SYNDROME IN THE PLATO (PLATELET INHIBITION AND PATIENT OUTCOMES) TRIAL</a><div class="gs_gray">A Bui, C Cannon, P Steg, R Storey, S Husted, F Ren, S James, ...</div><div class="gs_gray">Journal of the American College of Cardiology 63 (12S), A298-A298<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Role of admission cardiac biomarkers in risk stratification of patients with st-elevation myocardial infarction: insights from the platelet inhibition and patient outcomes trial</a><div class="gs_gray">M Velders, L Wallentin, R Becker, AJ van Boven, A Himmelmann, ...</div><div class="gs_gray">Journal of the American College of Cardiology 63 (12S), A18-A18<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:w0F2JDEymm0C" class="gsc_a_at">Ангиографические результаты в исследовании PLATO</a><div class="gs_gray">V Kunadian, SK James, DM Wojdyla, C Zorkun, J Wu, RF Storey, PG Steg, ...</div><div class="gs_gray">Кардіохірургія та інтервенційна кардіологія, 57-72<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Chemokine (CXC motif) ligand 16 (CXCL16) and osteoprotegerin (OPG) as predictors of outcome in patients with acute coronary syndromes (ACS) a PLATO biomarker substudy</a><div class="gs_gray">T Ueland, A Michelsen, P Aukrust, R Becker, M Bertilsson, SK James, ...</div><div class="gs_gray">European Heart Journal 35, 486-486<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:5MTHONV0fEkC" class="gsc_a_at">ApoA1 is independently associated with recurrent ischemic events and death in acute coronary syndrome patients</a><div class="gs_gray">A Oskarsson, C Varenhorst, E Hagström, ML Wernroth, RC Becker, ...</div><div class="gs_gray">European Heart Journal 35, 482-482<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Secreted wingless (Wnt) antagonists and risk prediction in acute coronary syndrome (ACS) a PLATO biomarker substudy</a><div class="gs_gray">T Ueland, P Aukrust, A Michelsen, M Bertilsson, SK James, ...</div><div class="gs_gray">European Heart Journal 35, 318-318<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:OTTXONDVkokC" class="gsc_a_at">Ангіографічні наслідки в дослідженні PLATO</a><div class="gs_gray">V Kunadian, SK James, DM Wojdyla, C Zorkun, J Wu, RF Storey, PG Steg, ...</div><div class="gs_gray">Кардіохірургія та інтервенційна кардіологія, 57-72<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:jFemdcug13IC" class="gsc_a_at">Evaluation of the Effect of Interleukin 18 Associated Genetic Polymorphisms on Risk of Cardiovascular Events in Patients With Acute Coronary Syndrome</a><div class="gs_gray">A Siegbahn, åsa Johansson, N Eriksson, E Hagström, C Varenhorst, ...</div><div class="gs_gray">Circulation 128 (suppl_22), A17262-A17262<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Genetic Polymorphism and Relationship to Cystatin C Concentrations and Outcome-Results From the Platelet Inhibition and Patient Outcomes Study</a><div class="gs_gray">A Akerblom, L Wallentin, A Siegbahn, RC Becker, A Budaj, ...</div><div class="gs_gray">Circulation 128 (suppl_22), A13713-A13713<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Response to Letter Regarding Article,“Ticagrelor in Patients With Acute Coronary Syndromes and Stroke: Interpretation of Subgroups in Clinical Trials”</a><div class="gs_gray">SK James, RF Storey, KS Pieper, CP Cannon, RC Becker, PG Steg, ...</div><div class="gs_gray">Stroke 44 (8), e95-e96<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Difference in causes of death between ticagrelor and clopidogrel in the PLATO trial</a><div class="gs_gray">C Varenhorst, U Alstrom, OÖ Braun, RF Storey, KW Mahaffey, C Cannon, ...</div><div class="gs_gray">European Heart Journal 34 (suppl_1)<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Evolving pattern of platelet P2Y12 inhibition during maintenance therapy in acute coronary syndrome patients: PB 1.21–1</a><div class="gs_gray">R Joshi, R Hossain, A Morton, R Ecob, H Judge, C Wales, A Karunakaran, ...</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Diabetes modulates the fibrinolytic properties of aspirin without altering the platelet inhibitory actions: a possible mechanism for aspirin treatment failure: PB 3.21–1</a><div class="gs_gray">Z Kurdee, A Mamaniat, F Phonix, P Rice, R Storey, P Grant, R Ajjan</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 11<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Zebrafish as a model to investigate the effect of P2Y12 knockdown on leukocyte migration</a><div class="gs_gray">R Bright, R Storey, T Chico</div><div class="gs_gray">JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11, 450-450<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:OR75R8vi5nAC" class="gsc_a_at">The role of vessel wall P2Y12 in early atherogenesis is not blocked by ticagrelor or clopidogrel</a><div class="gs_gray">LE West, T Steiner, SE Francis, RF Storey</div><div class="gs_gray">JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11, 156-156<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">Hypoglycemia Increases Platelet Reactivity in Patients With Type 2 Diabetes</a><div class="gs_gray">EYK Chow, A Iqbal, E Walkinshaw, AL Solomon, R Daly, HM Judge, ...</div><div class="gs_gray">DIABETES 62, A100-A100<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:KaMxkj08jr0C" class="gsc_a_at">YIA6: VESSEL WALL, BUT NOT PLATELET, P2Y12 CONTRIBUTES TO EARLY ATHEROGENESIS</a><div class="gs_gray">L West, S Francis, R Storey</div><div class="gs_gray">Heart 99 (suppl 2), A7-A7<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:nqdriD65xNoC" class="gsc_a_at">Corrigendum to: Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study [Eur Heart J 2019; 40: 678–685]. In the original version of&nbsp;…</a><div class="gs_gray">WJ Cantor, A Cequier, M Chettibi, SG Goodman, CJ Hammett, K Huber, ...</div><div class="gs_gray">Circulation 128, e362-e425<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Outcomes with ticagrelor versus clopidogrel in relation to high sensitivity troponin-T in non-ST-elevation acute coronary syndrome patients managed with early invasive or non&nbsp;…</a><div class="gs_gray">L Wallentin, S James, E Giannitsis, H Katus, RC Becker, CP Cannon, ...</div><div class="gs_gray">Pharmacotherapy 33 (10), E189-E189<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:AHdEip9mkN0C" class="gsc_a_at">Health economic evalatuion of ticagrelor compared to generic clopidogrel in patients with acute coronary syndromes (ACS) intended for non-invasive management based on the PLATO&nbsp;…</a><div class="gs_gray">SK James, RF Storey, C Cannon, M Janzon, JC Nicoloau, B Parasuraman, ...</div><div class="gs_gray">ESC Congress 2013, 31 August-04 September 2013, Amsterdam, Netherlands<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:bKqednn6t2AC" class="gsc_a_at">Zebrafish as a model to investigate the roles of the p2y12 receptor in vivo</a><div class="gs_gray">RJ Bright, RF Storey, TJ Chico</div><div class="gs_gray">Atherosclerosis 225 (2), e1<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ALROH1vI_8AC" class="gsc_a_at">Incidence and Predictors of Stent Thrombosis: A Review of 5,834 Consecutive Patients in a Single UK Centre</a><div class="gs_gray">J Iqbal, W Sumaya, V Tatman, M Whittaker, A Morton, S Campbell, ...</div><div class="gs_gray">Circulation 126 (suppl_21), A16792-A16792<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:48xauSegjOkC" class="gsc_a_at">Number of Antithrombotic Drugs and Association with In-Hospital Clinical Outcomes in Patients with Acute Coronary Syndromes: Results from the EPICOR Study</a><div class="gs_gray">H Bueno, RF Storey, N Danchin, JU Medina, M Licour, L Annemans, ...</div><div class="gs_gray">Circulation 126 (suppl_21), A11861-A11861<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">PHARMACODYNAMICS OF VORAPAXAR, A PLATELET PAR-1 ANTAGONIST, AND ITS INTERACTION WITH P2Y12 RECEPTOR PATHWAY IN THE TRACER TRIAL</a><div class="gs_gray">LK Jennings, D Moliterno, R Storey, E Hord, J Kotha, R Becker, S Smyth, ...</div><div class="gs_gray">Journal of the American College of Cardiology 59 (13S), E351-E351<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:cWzG1nlazyYC" class="gsc_a_at">RELATIONSHIP BETWEEN NONSUSTAINED VENTRICULAR TACHYCARDIA AND VASCULAR DEATH IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THE PLATO (PLATELET INHIBITION AND PATIENT OUTCOMES) TRIAL</a><div class="gs_gray">AH Bui, C Cannon, P Steg, R Storey, S Husted, F Ren, S James, ...</div><div class="gs_gray">Journal of the American College of Cardiology 59 (13S), E629-E629<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:QoJ_w57xiyAC" class="gsc_a_at">Cardiology Fellow X Factor: An ACS Case of Therapeutic Challenges</a><div class="gs_gray">RFW Storey, SD Humphrey, L Holly</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Effect of lactation stage and inflammatory mediators on the information flow in circulating bovine neutrophils</a><div class="gs_gray">M Stevens</div><div class="gs_gray">Ghent University<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Serial cystatin C measurements and changes in glomerular filtration rate as predictors for death or myocardial infarction in ACS patients</a><div class="gs_gray">A Åkerblom, L Wallentin, A Siegbahn, RC Becker, A Budaj, H Katus, ...</div><div class="gs_gray">European Heart Journal 33 (Suppl 1), 135-135<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Corrigendum to: Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial</a><div class="gs_gray">A BUDAJ, DM WOJDYLA, SK JAMES, JH CORNEL, J FRENCH, C HELD, ...</div><div class="gs_gray">European heart journal 33 (21)<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Vorapaxar in ACS patients undergoing CABG surgery: results from the TRACER trial</a><div class="gs_gray">P Tricoci, DJ Whellan, P Vranckx, D Leibovitz, Z Huang, J Strony, ...</div><div class="gs_gray">European Heart Journal<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Availability of cath lab facilities and contemporary inter-hospital transfer patterns for the management of ACS patients: findings from the EPICOR study</a><div class="gs_gray">PR Sinnaeve, H Bueno, N Danchin, J Sanchez-Covisa, M Licour, ...</div><div class="gs_gray">Congress of the European Society of Cardiology (ESC) 33 (suppl. 1), 145-145<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">ESC/EAS Kilavuzlari: Dislipidemilerin tedavisi</a><div class="gs_gray">Ž Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray">Turk Kardiyoloji Dernegi Arsivi 39 (SUPP-3), 5-72<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">Ticagrelor: novel antithrombotic for acute coronary syndromes</a><div class="gs_gray">S Chaplin, RF Storey</div><div class="gs_gray">Prescriber 22 (21), 20-25<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:CB2v5VPnA5kC" class="gsc_a_at">Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention-an analysis from the prospective&nbsp;…</a><div class="gs_gray">PG Steg, RA Harrington, R Storey, H Emanuelsson, H Katus, K Mahaffey, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 32, 415-416<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:owLR8QvbtFgC" class="gsc_a_at">ANGIOGRAPHIC OUTCOMES IN THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL</a><div class="gs_gray">V Kunadian, C Zorkun, S James, J Wu, A Muhammad, R Storey, PG Steg, ...</div><div class="gs_gray">Journal of the American College of Cardiology 57 (14S), E946-E946<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:otzGkya1bYkC" class="gsc_a_at">Interventional Pharmacotherapy</a><div class="gs_gray">ED Grech, RF Storey</div><div class="gs_gray">ABC of Interventional Cardiology 149<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:xyvS_IvSCKsC" class="gsc_a_at">Guía de la ESC/EAS sobre el manejo de las dislipemias</a><div class="gs_gray">AL Catapano, G De Backer, I Graham, M Taskinen, O Wiklund, S Agewall, ...</div><div class="gs_gray">Revista Española de Cardiología 64 (12), 1168-1168<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Stabilizing role of platelet P2Y</a><div class="gs_gray">R Nergiz-Unal, JMEM Cosemans, MAH Feijge, PEJ van der Meijden, ...</div><div class="gs_gray">Platelets in atherothrombosis 12 (5), 107<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Erratum to ESC/EAS Guidelines for the management of dyslipidaemias</a><div class="gs_gray">A FORCE, AL CATAPANO, Z REINER, G DE BACKER, I GRAHAM, ...</div><div class="gs_gray">Atherosclerosis 217 (1)<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Editor's Choice: Fast Track: Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes&nbsp;…</a><div class="gs_gray">S James, DJ Angiolillo, JH Cornel, D Erlinge, S Husted, F Kontny, J Maya, ...</div><div class="gs_gray">European Heart Journal 31 (24), 3006<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Sustained P2Y12 Receptor Inhibition is Required to Effectively Inhibit Neointima Formation in a Murine Vascular Injury Model</a><div class="gs_gray">SB Patil, LE Jackman, SE Francis, HM Judge, S Nylander, RF Storey</div><div class="gs_gray">Circulation 122 (suppl_21), A12530-A12530<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:6yz0xqPARnAC" class="gsc_a_at">Stability of Metabolic Syndrome During the Transition to Adulthood: A 7-Year Follow Up Study</a><div class="gs_gray">E Goodman, LM Dolan, SR Daniels</div><div class="gs_gray">Circulation 122 (suppl_21), A10180-A10180<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Sustained P2Y12 Receptor Inhibition is Required to Effectively Inhibit Neointima Formation in a Murine Vascular Injury Model</a><div class="gs_gray">SB Patil, LE Jackman, SE Francis, HM Judge, S Nylander, RF Storey</div><div class="gs_gray">Circulation 122 (suppl_21), A12530-A12530<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:u-coK7KVo8oC" class="gsc_a_at">First Analysis of Relation Between CYP2C19 Genotype and Platelet Function in Ticagrelor versus Clopidogrel Treated Patients: Results from the ONSET/OFFSET and RESPOND Studies</a><div class="gs_gray">PA Gurbel, K Bliden, RF Storey, C Wei, M Armstrong, K Butler, US Tantry</div><div class="gs_gray">Circulation 122 (suppl_21), A20393-A20393<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">First Analysis of Relation Between CYP2C19 Genotype and Platelet Function in Ticagrelor versus Clopidogrel Treated Patients: Results from the ONSET/OFFSET and RESPOND Studies</a><div class="gs_gray">PA Gurbel, K Bliden, RF Storey, C Wei, M Armstrong, K Butler, US Tantry</div><div class="gs_gray">Circulation 122 (suppl_21), A20393-A20393<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">POS10 Variability in patient response to clopidogrel and effects on outcome from carotid stenting</a><div class="gs_gray">M Randall, RF Storey, GS Venables, PA Gaines, TJ Cleveland</div><div class="gs_gray">Journal of Neurology, Neurosurgery &amp; Psychiatry 81 (11), e69-e70<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Ticagrelor versus clopidogrel in patients with acute coronary syndromes and diabetes in the PLATO trial</a><div class="gs_gray">S James, DJ Angiolillo, RC Becker, JH Cornel, J Horrow, S Husted, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 31, 202-202<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Function in Patients With Acute Coronary Syndromes The PLATO (PLATelet inhibition and patient Outcomes) PLATELET Substudy. J Am Coll Cardiol 2010; 56: 1456–62.</a><div class="gs_gray">RF Storey, DJ Angiolillo, SB Patil</div><div class="gs_gray">Journal of the American College of Cardiology 56 (22)<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">Antiplatelet therapy for acute coronary syndrome treated with percutaneous coronary intervention: New Developments Introduction</a><div class="gs_gray">JL Lopez-Sendon, RF Storey</div><div class="gs_gray">EUROPEAN HEART JOURNAL SUPPLEMENTS 11 (G), G2-G3<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">PLATO-Invasive: Comparison of Ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes with a planned&nbsp;…</a><div class="gs_gray">CP Cannon, R Becker, H Emanuelsson, R Harrington, J Horrow, S Husted, ...</div><div class="gs_gray">AMERICAN JOURNAL OF CARDIOLOGY 104 (6 A), XVIII-XVIII<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:J3LtWjKFLicC" class="gsc_a_at">Rifampicin increases the extent of P2Y12 receptor blockade achieved by clopidogrel administration: OC-MO-012</a><div class="gs_gray">S Patil, H Judge, R Buckland, J Jakubowski, R Storey</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 7<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:z_wVstp3MssC" class="gsc_a_at">Reversible binding of cangrelor to the P2Y12 receptor prevents the binding of clopidogrel and prasugrel active metabolites: PP-TH-030</a><div class="gs_gray">R Buckland, H Judge, A Sugidachi, J Jakubowski, R Storey</div><div class="gs_gray">Journal of Thrombosis and Haemostasis 7<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Rifampicin increases the extent of P2Y12 receptor blockade achieved by clopidogrel administration</a><div class="gs_gray">SBG Patil, HM Judge, RJ Buckland, RF Storey</div><div class="gs_gray">Heart 95 (Suppl 1), 84-84<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:jgBuDB5drN8C" class="gsc_a_at">Platelet physiology and the role of the platelet in ischemic heart</a><div class="gs_gray">RF Storey</div><div class="gs_gray">The AHA Clinical Series, 1<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:hvmnpdAuIbkC" class="gsc_a_at">MRS 2395</a><div class="gs_gray">LE Jackman, RF Storey</div><div class="gs_gray">Elsevier<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Prasugrel</a><div class="gs_gray">LE Jackman, RF Storey</div><div class="gs_gray">Elsevier<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:silx2ntsSuwC" class="gsc_a_at">Platelet Physiology and the Role of the Platelet in Ischemic Heart Disease</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Antiplatelet Therapy In Ischemic Heart Disease, 1-14<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Platelet function assays that assess response to P2Y12 antagonists vary widely in their sensitivities to low levels of P2Y12 receptor blockade</a><div class="gs_gray">HM Judge, RJ Buckland, A Sugidachi, JA Jakubowski, RF Storey</div><div class="gs_gray">EUROPEAN HEART JOURNAL 29, 835-835<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Final aggregation response is a more sensitive marker of the effects of P2Y12 receptor antagonists than maximal aggregation response</a><div class="gs_gray">RF Storey, CP Cannon, RA Harrington, PM Sandset, S Heptinstall, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 29, 405-405<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Abciximab can potentiate platelet alpha-granule release and this effect is prevented by the P2Y12 antagonist cangrelor</a><div class="gs_gray">HM Judge, RF Storey</div><div class="gs_gray">EUROPEAN HEART JOURNAL 28, 665-666<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:2vr6o8x5NLkC" class="gsc_a_at">AR-C69931MX</a><div class="gs_gray">RF Storey</div><div class="gs_gray">Elsevier<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:cRMvf6lLvU8C" class="gsc_a_at">AZD6140, a reversible oral ADP receptor antagonist, does not increase risk of bleeding vs the thienopyridine clopidogrel in patients undergoing CABG surgery in the DISPERSE2 trial</a><div class="gs_gray">S Husted, RA Harrington, CP Cannon, RF Storey, M Wickens, D Price, ...</div><div class="gs_gray">AMERICAN JOURNAL OF CARDIOLOGY 98 (8 A), 204M-204M<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PYBJJbyH-FwC" class="gsc_a_at">The G allele of the platelet P2Y1 1622 A&gt; G polymorphism is not associated with platelet hyper-reactivity to ADP in either healthy volunteers or CAD patients</a><div class="gs_gray">SMG Smith, HM Judge, ME Daly, RF Storey</div><div class="gs_gray">EUROPEAN HEART JOURNAL 27, 756-756<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">286 THE P2Y12 RECEPTOR REGULATES THE VESSEL WALL RESPONSE TO ARTERIAL INJURY AND THROMBOSIS</a><div class="gs_gray">D Evans, D Crosdale, K Norman, S Francis, R Storey</div><div class="gs_gray">Heart 92<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:4vMrXwiscB8C" class="gsc_a_at">288 PLATELET PROTEASE-ACTIVATED RECEPTOR 1 DENSITY, TRAP-INDUCED PLATELET RESPONSES, AND THE EFFECT OF COMPLETE P2Y12 RECEPTOR BLOCKADE</a><div class="gs_gray">S Smith, H Judge, M Daly, R Storey</div><div class="gs_gray">Heart 92<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Cardiovascular Biology and Cell Signalling-Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes&nbsp;…</a><div class="gs_gray">A Siotia, R Buckland, HM Judge, P Sastry, RF Storey</div><div class="gs_gray">Thrombosis and Haemostasis 95 (6), 997-1002<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Partial P2Y12 receptor blockade by clopidogrel may not be overcome by increasing the clopidogrel dose</a><div class="gs_gray">H Judge, R Buckland, D Crosdale, RF Storey</div><div class="gs_gray">EUROPEAN HEART JOURNAL 26, 487-487<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:8dzOF9BpDQoC" class="gsc_a_at">Platelets and Blood Cells-Agonists of toll-like receptor (TLR) 2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor</a><div class="gs_gray">JR Ward, L Bingle, HM Judge, SB Brown, RF Storey, MKB Whyte, ...</div><div class="gs_gray">Thrombosis and Haemostasis 94 (4), 831-838<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">A randomized double blind comparison of two strategies for managing patients on aspirin and clopidogrel therapy requiring urgent coronary revascularization</a><div class="gs_gray">V Shrivastava, E Akowuah, B Jamnadas, R Storey, M Matuszewski, ...</div><div class="gs_gray">CIRCULATION 110 (17), 356-356<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Anticoagulants, antiplatelets and thrombolytics</a><div class="gs_gray">RF Storey</div><div class="gs_gray">British Journal of Clinical Pharmacology 58 (4), 442-442<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:AXkvAH5U_nMC" class="gsc_a_at">Gene sequence variations influence platelet reactivity before and during clopidogrel therapy</a><div class="gs_gray">SMG Smith, HM Judge, G Peters, M Armstrong, P Fontana, P Gaussem, ...</div><div class="gs_gray">EUROPEAN HEART JOURNAL 25, 237-237<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">P1709 Effects of clopidogrel on platelet calcium mobilisation in acute coronary syndrome patients</a><div class="gs_gray">MWH Behan, SC Fox, RF Storey, S Heptinstall</div><div class="gs_gray">European Heart Journal 5 (24), 323<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:WC23djZS0W4C" class="gsc_a_at">Inhibition of ADP-induced platelet-leukocyte conjugate formation by clopidogrel and AR-C69931MX</a><div class="gs_gray">RF Storey, HM Judge, RG Wilcox, S Heptinstall</div><div class="gs_gray">EUROPEAN HEART JOURNAL 23, 722-722<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Aul-kAQHnToC" class="gsc_a_at">P2T receptor activation by released ADP dramatically amplifies platelet procoagulant activity and calcium mobilisation induced by thrombin receptor (PAR1) activation</a><div class="gs_gray">RF Storey, HM Sanderson, S Heptinstall</div><div class="gs_gray">EUROPEAN HEART JOURNAL 21, 66-66<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">O4 Heparins sensitize platelets to responses mediated via both the P27 and the P2Y1 receptor pathways</a><div class="gs_gray">RF Storey, JA May, S Heptinstall</div><div class="gs_gray">Blood Coagulation &amp; Fibrinolysis 10 (8), 531<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Contribution of P-2t, and P2Y (1), receptors to ADP-induced platelet microaggregation in human whole blood</a><div class="gs_gray">RF Storey, KE Cameron, LJ Newby, JA May, RG Wilcox, S Heptinstall</div><div class="gs_gray">THROMBOSIS AND HAEMOSTASIS, 260-260<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Monitoring the Effects of Glycoprotein IIb/IIIa Antagonists using a Whole Blood Assay of Platelet Microaggregation</a><div class="gs_gray">RF Storey, JA May, RG Wilcox, S Heptinstall</div><div class="gs_gray">Hämostaseologie 19 (03), 115-118<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:3htObqc8RwsC" class="gsc_a_at">Clinical Investigation and Reports-Differential Effects of Glycoprotein IIb/IIIa Antagonists on Platelet Microaggregate and Macroaggregate Formation and Effect of Anticoagulant&nbsp;…</a><div class="gs_gray">RF Storey, RG Wilcox, S Heptinstall</div><div class="gs_gray">Circulation 98 (16), 1616-1621<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PuOEWVtPfzwC" class="gsc_a_at">ISCHEMIC HEART DISEASE</a><div class="gs_gray">M Thomas, J Shillingford</div><div class="gs_gray">Anesthesiology 26 (6)<span class="gs_oph">, 1965</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1965</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Nufq_to8ts0C" class="gsc_a_at">Online supplement for “Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients&nbsp;…</a><div class="gs_gray">RF Storey, PA Gurbel, J ten Berg, C Bernaud, GD Dangas, JM Frenoux, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:rFyVMFCKTwsC" class="gsc_a_at">Platelets and the Endothelium Funding Footnotes References</a><div class="gs_gray">WAE Parker, RF Storey</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yJjnfzR0HrkC" class="gsc_a_at">Randomised Controlled Trial of Early CT Coronary Angiography in Patients With Suspected Acute Coronary Syndrome</a><div class="gs_gray">AJ Gray, C Roobottom, JE Smith, S Goodacre, K Oatey, R O’Brien, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:cNe27ouKFcQC" class="gsc_a_at">Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite P2Y12 Inhibition</a><div class="gs_gray">A Braza-Boïls, T Barwari, C Gutmann, MR Thomas, HM Judge, A Joshi, ...</div><div class="gs_gray">Int J Mol Sci 2020 21, E2897<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:In6cVmBjs0IC" class="gsc_a_at">PMCID: PMC3233986.</a><div class="gs_gray">L Wallentin, E Chen, Y Lokhnygina, J Pei, S Leonardi, TL Rorick, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:M0leSnx2MbUC" class="gsc_a_at">VASCULAR DISEASE</a><div class="gs_gray">BCA CALCIFICATION</div><div class="gs_gray">VASCULAR 55 (10A)<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:AzKEL7Gb_04C" class="gsc_a_at">EHRA CONSENSUS DOCUMENT</a><div class="gs_gray">GYH Lip, JP Collet, M Haude, S Halvorsen, D Lau, N Lopez-Cabanillas, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Our thanks to all those who have helped with this issue of Biomarkers in Medicine. Listed below are authors, referees and others who have kindly given their time, effort and&nbsp;…</a><div class="gs_gray">E Barbato, CM Barker, K Bliden, J Brown, K Camphausen, G Campo, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Blood Clot Structure and Fibrinolysis in Cardiovascular Conditions</a><div class="gs_gray">S Atkin, R Storey, M Strachan, A Zaman</div><div class="gs_gray">Diabetologia 51, 385-390<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">Dual antiplatelet therapy following acute coronary syndromes: optimal regimens and duration of therapy</a><div class="gs_gray">W Sumaya, RF Storey</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">Our thanks to all those who have helped with this issue of Biomarkers in Medicine. Listed below are authors, referees and others who have kindly given their time, effort and&nbsp;…</a><div class="gs_gray">D Alvaro, S Arques, H Balci, J Bartunek, S Batra, T Bezabeh, J Blanc, J Bo, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">PLATO, ATLAS, and Mortality: Implications for Clinical Practice CME</a><div class="gs_gray">DL Bhatt, RF Storey, CM Gibson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Population Approach Group Europe Population Approach Group Europe</a><div class="gs_gray">T Matsuura</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Genetics of Cardiovascular Disease, Vol 124. Progress in Molecular Biology and Translational Science</a><div class="gs_gray">SE Francis, B Chaudhry, D Henderson, A Rothman, RN Wilkinson, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Corrigendum 2750</a><div class="gs_gray">A Budaj, DM Wojdyla, SK James, JH Cornel, J French, C Held, J Horrow, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Journal of Cardiovascular Translational Research</a><div class="gs_gray">P Fontana, A Zufferey, Y Daali, JL Reny</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Trial Designs</a><div class="gs_gray">D Lindholm, RF Storey, S Halvorsen, EL Grove, OÖ Braun, C Varenhorst, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Applying Data to Practice: Expert Perspectives in Acute Coronary Syndrome Management CME</a><div class="gs_gray">RF Storey, C Hamm, JM Hill, G Montalescot</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Triple therapy for atrial fibrillation and PCI: A contemporary review</a><div class="gs_gray">W Dewilde, P Janssen, F Verheugt, R Storey, T Adriaenssens, ...</div><div class="gs_gray">Optimal antiplatelet and anticoagulant therapy in patients with oral&nbsp;…<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:GFxP56DSvIMC" class="gsc_a_at">Rational Pharmacotherapy in Cardiology</a><div class="gs_gray">Z Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Association of MicroRNAs and YRNAs with Platelet Function</a><div class="gs_gray">ER Zampetaki, S Ye, TD Warner, A Saxena, S Kiechl, RF Storey, M Mayr</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=-plVGtcAAAAJ&amp;cstart=600&amp;pagesize=100&amp;citation_for_view=-plVGtcAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">TITLE: Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With&nbsp;…</a><div class="gs_gray">CP Cannon, S Husted, RA Harrington, BM Scirica, H Emanuelsson, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–639</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>